Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning
Open accessAbstract
The up-regulation of α4β2* nicotinic acetylcholine receptors (nAChRs) by chronic nicotine is a cell-delimited process and may be necessary and sufficient for the initial events of nicotine dependence. Clinical literature documents an inverse relationship between a person’s history of tobacco use and his or her susceptibility to Parkinson’s disease; this may also result from up-regulation. This study visualizes and quantifies the subcellular mechanisms involved in nicotine-induced nAChR up-regulation by using transfected fluorescent protein (FP)-tagged α4 nAChR subunits and an FP-tagged Sec24D endoplasmic reticulum (ER) exit site marker. Total internal reflection fluorescence microscopy shows that nicotine (0.1 µM for 48 h) up-regulates α4β2 nAChRs at the plasma membrane (PM), despite increasing the fraction of α4β2 nAChRs that remain in near-PM ER. Pixel-resolved normalized Förster resonance energy transfer microscopy between α4-FP subunits shows that nicotine stabilizes the (α4)2(β2)3 stoichiometry before the nAChRs reach the trans-Golgi apparatus. Nicotine also induces the formation of additional ER exit sites (ERES). To aid in the mechanistic analysis of these phenomena, we generated a β2enhanced-ER-export mutant subunit that mimics two regions of the β4 subunit sequence: the presence of an ER export motif and the absence of an ER retention/retrieval motif. The α4β2enhanced-ER-export nAChR resembles nicotine-exposed nAChRs with regard to stoichiometry, intracellular mobility, ERES enhancement, and PM localization. Nicotine produces only small additional PM up-regulation of α4β2enhanced-ER-export receptors. The experimental data are simulated with a model incorporating two mechanisms: (1) nicotine acts as a stabilizing pharmacological chaperone for nascent α4β2 nAChRs in the ER, eventually increasing PM receptors despite a bottleneck(s) in ER export; and (2) removal of the bottleneck (e.g., by expression of the β2enhanced-ER-export subunit) is sufficient to increase PM nAChR numbers, even without nicotine. The data also suggest that pharmacological chaperoning of nAChRs by nicotine can alter the physiology of ER processes.
AI snapshot
Written from the paper’s full text.
TL;DR
Chronic nicotine up-regulates α4β2 nicotinic receptors by acting in the ER as a stoichiometry-dependent pharmacological chaperone that stabilizes (α4)₂(β2)₃ receptors and increases ER exit sites, allowing more receptors to reach the plasma membrane despite an ER export bottleneck. The β2 M3–M4 loop’s ER export (LFM) and retention/retrieval (RRQR) motifs set this balance, and an enhanced-ER-export β2 mutant mimics nicotine’s effects.
Key findings
- Nicotine (0.1 µM, 48 h) up-regulated wild-type α4β2 nAChRs at the plasma membrane 1.9-fold, while the whole TIRF footprint/ER ratio fell from 3.42 to 2.19, indicating a larger fraction of receptors remained ER-resident.
- NFRET showed nicotine shifted α4β2 stoichiometry toward (α4)₂(β2)₃: for wild-type β2, whole-cell A1/(A1+A2) rose from 0.51 to 0.73, and in the TG/TGN from 0.36 to 0.83. β2-L349M and β2-365AAQA368 were already biased toward (α4)₂(β2)₃ and nicotine further increased this (e.g., TG/TGN 0.69→0.82 and 0.63→0.74).
- The β2 enhanced-ER-export double mutant (β2-365AAQA368 L349M) increased PM-integrated density 2.36-fold versus wild type without nicotine; nicotine added only 1.2-fold more, and footprint/ER ratio was 8.18 versus 3.42 for wild type, rising to 9.19 with nicotine. β2-365AAQA368 alone increased PM density 1.74-fold versus wild type, with a further 1.65-fold after nicotine; footprint/ER ratio was 5.33 and 8.53, respectively.
- Nicotine doubled ERES from ∼25 to ∼50 per cell in α4β2-expressing cells, with no effect in cells without nAChR expression or expressing GluCl; ERES number increased monotonically with LFM motifs (∼17 with zero, ∼30 with wild type, ∼52 with five LFM motifs). The SePhaChARNS 2.0 model indicated nicotine chaperones nAChRs in the ER, enhancing an endogenous process by a factor of 10–30, with no required post-ER flux limitation.
Methods
- Live-cell TIRF, confocal, and pixel-resolved NFRET microscopy in transiently transfected mouse Neuro-2a cells expressing fluorescent-protein-tagged α4 subunits plus wild-type or mutant β2 subunits, Sec24D-mcherry ERES marker, and GalT-eCFP TG/TGN marker; nicotine treatment was 0.1 µM for 48 h.
- TIRF images were quantified by PM- and ER-integrated densities and whole-footprint/ER ratios; NFRET histograms were fitted to two Gaussian components corresponding to (α4)₂(β2)₃ and (α4)₃(β2)₂ stoichiometries; ERES were counted after Sec24D-mcherry thresholding.
- A kinetic model, SePhaChARNS 2.0, was optimized to six experimental target measures using MATLAB and a genetic algorithm; TIRF data typically involved 15–50 cells per group, and confocal data 30–40 cells per dish.
Limitations
- Stated: the authors cannot state that FP-labeled subunits perfectly emulate unlabeled subunits, although previous measurements detected no differences; NFRET could not systematically study unlabeled COPI/COPII structures, peripheral trafficking vesicles, endosomes, or lysosomes.
- Stated: SePhaChARNS 2.0 failed to predict the 1.86-fold ERES increase in the enhanced-ER-export double mutant without nicotine unless k_F→ERES for wild type was ∼10-fold lower than the exemplar value, so additional mechanisms may be required; future time-resolved measurements are needed and must account for FP maturation (typically 10³–10⁴ s).
- Evident: the study uses heterologous transient expression in Neuro-2a cells with mouse subunits and a fixed in vitro nicotine exposure (0.1 µM, 48 h), so the findings are not directly in vivo; the paper argues relevance from prior work in clonal cells, neurons, bronchial epithelium, and mice.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 53 cited sources checked · 0 supported · 0 flagged
- Findingown data
Nicotine (0.1 μM for 48 h) increases the fraction of α4β2 nAChRs that remain in near-PM ER.
“Total internal reflection fluorescence microscopy shows that nicotine (0.1 µM for 48 h) up-regulates α4β2 nAChRs at the plasma membrane (PM), despite increasing the fraction of α4β2 nAChRs that remain in near-PM ER.”
Quote in the paperSubstantial claim - Findingown data
The PM up-regulation of wild-type nAChRs by nicotine amounts to 1.9-fold.
“The PM up-regulation of wt nAChRs by nicotine, which amounts to 1.9-fold, recapitulates many experiments cited in the Introduction in various systems.”
Quote in the paperNot a substantial claim - Findingown data
α4β2 nAChRs primarily localize to the ER.
“Collectively, these data provide evidence that α4β2 nAChRs primarily localize to the ER, and that β subunits partially control the subcellular localization and trafficking of α4β2 and α4β4 nAChRs, explaining many previous studies in which α4β4 nAChRs show better surface expression than α4β2.”
Quote in the paperSubstantial claim - Findingown data
Nicotine induces the formation of additional ER exit sites (ERES).
“Nicotine also induces the formation of additional ER exit sites (ERES).”
Quote in the paperSubstantial claim - Findingown data
The α4β2enhanced-ER-export nAChR resembles nicotine-exposed nAChRs with regard to stoichiometry, intracellular mobility, ERES enhancement, and PM localization.
“The α4β2enhanced-ER-export nAChR resembles nicotine-exposed nAChRs with regard to stoichiometry, intracellular mobility, ERES enhancement, and PM localization.”
Quote in the paperSubstantial claim
- Findingown data
The study identifies novel motifs governing the ER localization of α4β2 nAChRs within the β2 subunit M3-M4 large intracellular loop.
“Furthermore, we identify novel motifs governing the ER localization of α4β2 nAChRs within the β2 subunit M3–M4 large intracellular loop and show that these motifs modulate the stoichiometry and ER exit of α4β2 nAChRs.”
Quote in the paperSubstantial claim - Findingown data
The ER pixel count showed an approximate twofold reduction for α4eGFP plus β4wt compared with α4eGFP plus β2wt-transfected cells.
“We observed that the ER pixel count showed an approximate twofold reduction for α4eGFP plus β4wt compared with α4eGFP plus β2wt–transfected cells (Fig. 1 D, 1 and 2).”
Quote in the paperSubstantial claim - Findingown data
Nicotine produces only small additional PM up-regulation of α4β2enhanced-ER-export receptors.
“Nicotine produces only small additional PM up-regulation of α4β2enhanced-ER-export receptors.”
Quote in the paperSubstantial claim - Findingown data
Nicotine (0.1 μM for 48 h) up-regulates α4β2 nAChRs at the plasma membrane.
“Total internal reflection fluorescence microscopy shows that nicotine (0.1 µM for 48 h) up-regulates α4β2 nAChRs at the plasma membrane (PM), despite increasing the fraction of α4β2 nAChRs that remain in near-PM ER.”
- Also stated in: § α4β2 nAChR up-regulation monitored optically · plain
“The PM up-regulation of wt nAChRs by nicotine, which amounts to 1.9-fold, recapitulates many experiments cited in the Introduction in various systems.”
Quote in the paperSubstantial claim - Also stated in: § α4β2 nAChR up-regulation monitored optically · plain
- Findingown data
α4eGFP plus β4wt-transfected cells showed a 1.9-fold increase in PM-integrated density compared with α4eGFP plus β2wt-transfected cells.
“We found that α4eGFP plus β4wt–transfected cells showed a 1.9-fold increase in the PM-integrated density when compared with α4eGFP plus β2wt–transfected cells (Fig. 1 B, 3).”
Quote in the paperSubstantial claim - Findingown data
Nicotine stabilizes the (α4)2(β2)3 stoichiometry before the nAChRs reach the trans-Golgi apparatus.
“Pixel-resolved normalized Förster resonance energy transfer microscopy between α4-FP subunits shows that nicotine stabilizes the (α4)2(β2)3 stoichiometry before the nAChRs reach the trans-Golgi apparatus.”
Quote in the paperSubstantial claim - Findingnone given
A majority of α4β2 nAChRs localize to the ER.
“Because a majority of α4β2 nAChRs localized to the ER, we were interested in analyzing putative ER export and ER retention/retrieval signals and their effects on nicotine-induced up-regulation.”
Quote in the paperSubstantial claim - Findingown data
Compared with untreated α4-eGFPβ2-365AAQA368-expressing cells, nicotine treatment results in a further 1.65-fold increase in PM-integrated density of α4-eGFPβ2-365AAQA368.
“When compared with untreated α4-eGFPβ2-365AAQA368–expressing cells, nicotine treatment resulted in a further 1.65-fold increase in the PM-integrated density of α4-eGFPβ2-365AAQA368.”
Quote in the paperSubstantial claim - Findingown data
Nicotine up-regulates enhanced ER export double-mutant nAChRs at the plasma membrane to a smaller extent than wild-type receptors.
“nicotine up-regulates enhanced ER export double-mutant nAChRs at the PM to a smaller extent than wt receptors.”
Quote in the paperSubstantial claim - Findingown data
Approximately 90% of α4-eGFP plus β2wt-transfected cells show ER- and PM-localized receptors.
“∼90% of α4-eGFP plus β2wt–transfected cells showed ER- and PM-localized receptors (Fig. 4 A, first column).”
Quote in the paperSubstantial claim - Findingown data
Treatment of α4eGFPβ2 double-mutant nAChR-transfected cells with 0.1 μM nicotine for 48 h increases the footprint/ER ratio only slightly further, to 9.19.
“Treatment of α4eGFPβ2 double-mutant nAChR-transfected cells with 0.1 µM nicotine for 48 h increased the footprint/ER ratio only slightly further, to 9.19.”
Quote in the paperSubstantial claim - Findingown data
Nicotine causes an up-regulation of wild-type α4β2 nAChRs at the plasma membrane.
“nicotine causes an up-regulation of wt α4β2 nAChRs at the PM”
Quote in the paperSubstantial claim - Findingown data
48-h exposure of α4eGFPβ2 double-mutant nAChRs to 0.1 μM nicotine causes only a small additional increase in PM-integrated density (1.2-fold).
“48-h exposure of α4eGFPβ2 double-mutant nAChRs to 0.1 µM nicotine caused only a small additional increase in PM-integrated density (1.2-fold)”
Quote in the paperSubstantial claim - Findingown data
Mouse β2 subunits possess an RRQR sequence (amino acids 365-368) that is absent in mouse β4.
“Mouse β2 subunits possess an RRQR sequence (amino acids 365–368) that is absent in mouse β4 (Fig. 2 D, 1).”
Quote in the paperSubstantial claim - Findingown data
In cells cotransfected with α4-mcherry plus β2wt and stained with ER-Tracker Green, the red and green fluorescence colocalized nearly completely.
“To prove this point, we cotransfected cells with α4-mcherry plus β2wt and then stained them with ER-Tracker Green; the red and green fluorescence colocalized nearly completely (Fig. 1 A, third column).”
Quote in the paperSubstantial claim - Findingown data
In the absence of nicotine, α4eGFPβ2 double-mutant nAChRs show a 2.36-fold increase in PM-integrated density compared with wild-type receptors.
“In the absence of nicotine, the α4eGFPβ2 double-mutant nAChRs showed a 2.36-fold increase in PM-integrated density compared with wt receptors.”
Quote in the paperSubstantial claim - Findingown data
α4-eGFP plus β2wt-transfected cells demonstrated reticulate eGFP labeling that resembled ER.
“α4-eGFP plus β2wt–transfected cells demonstrated reticulate eGFP labeling that resembled ER (Fig. 1 A, compare the first and second columns).”
Quote in the paperSubstantial claim - Findingown data
Nicotine has no effect on ERES number in the absence of nAChR expression.
“In Fig. 6 E, the first set of bars show that nicotine had no effects on ERES number in the absence of nAChR expression.”
Quote in the paperSubstantial claim - Findingown data
For (α4)2(β2-L349M)3 nAChR, nicotine changes A1/(A1 + A2) from 0.69 to 0.82 in the TG/TGN.
“For the (α4)2(β2-L349M)3 nAChR, nicotine induced a change in A1/(A1 + A2) from the already elevated value of 0.69 to 0.82.”
Quote in the paperSubstantial claim - Findingown data
In the presence of nicotine (0.1 μM for 48 h), ERES are at least as plentiful.
“In the presence of nicotine (0.1 µM for 48 h), the ERES were at least as plentiful (Video 5).”
Quote in the paperSubstantial claim - Findingown data
In whole cell optical sections, the majority of the intracellular fluorescent signal from α4-FPβ2 nAChRs localizes to the ER.
“In whole cell optical sections, the majority of the intracellular fluorescent signal from α4-FPβ2 nAChRs also localizes to the ER.”
Quote in the paperSubstantial claim - Findingown data
Most of the remaining intracellular α4-FPβ2 nAChRs localize to the trans-Golgi apparatus.
“Our NFRET experiments used a GalTeCFP marker to delineate the trans-Golgi apparatus, where we find most of the remaining intracellular α4-FPβ2 nAChRs.”
Quote in the paperNot a substantial claim - Findingown data
The average number of ERES increases monotonically with the number of LFM export motifs present in wt and mutant nAChRs.
“When ERES number (y axis) is displayed versus the number of LFM motifs (x axis) per pentamer, the average number of ERES increased monotonically with the number of LFM export motifs present in wt and mutant nAChRs (Fig. 6 C).”
Quote in the paperSubstantial claim - Findingown data
When ERES are counted in cells transfected with α4β2 nAChRs, nicotine causes a twofold increase in ERES from ∼25 to ∼50 per cell.
“However, when ERES were counted in cells transfected with α4β2 nAChRs, nicotine caused a twofold increase in ERES from ∼25 to ∼50 per cell (Fig. 6 E).”
Quote in the paperSubstantial claim - Findingown data
48-h nicotine exposure increases the proportion of (α4)2(β2wt)3 nAChR pixels from A1/(A1 + A2) = 0.51 to 0.73 in the whole cell section ROI.
“In the case of whole cell section NFRET measurements, 48-h nicotine exposure caused an increase in the proportion of (α4)2(β2wt)3 nAChR pixels, from A1/(A1 + A2) = 0.51 to 73, in the whole cell section ROI.”
Quote in the paperSubstantial claim - Findingown data
The effect of nicotine on ERES number is specific to nAChR expression because nicotine does not increase ERES in cells transfected with C. elegans GluCl.
“This effect of nicotine was specific to nAChR expression because nicotine did not increase ERES in parallel control experiments of cells transfected with C. elegans GluCl.”
Quote in the paperSubstantial claim - Findingown data
For (α4)2(β2-365AAQA368)3 pixels, the nicotine-free value of 0.63 is further increased by nicotine to 0.74 in the TG/TGN.
“The already elevated nicotine-free value of 0.63 for (α4)2(β2-365AAQA368)3 pixels was further increased by nicotine to 0.74.”
Quote in the paperSubstantial claim - Findingown data
α4-eGFPβ4wt receptors demonstrate ∼47 ERES per cell, significantly higher than ∼34 ERES per cell in α4L358A-eGFPβ4wt-transfected cells (P < 0.01).
“α4-eGFPβ4wt receptors demonstrated ∼47 ERES per cell, which was significantly higher than the number of ERES (∼34 per cell) in α4L358A-eGFPβ4wt–transfected cells (P < 0.01).”
Quote in the paperSubstantial claim - Findingown data
In the TG/TGN ROI, nicotine increases the proportion of (α4)2(β2wt)3 nAChR pixels from A1/(A1 + A2) = 0.36 to 0.83.
“NFRET measurements on the TG/TGN ROI showed that nicotine induced a dramatic increase in the proportion of (α4)2(β2wt)3 nAChR pixels, from A1/(A1 + A2) = 0.36 to 0.83.”
Quote in the paperSubstantial claim - Findingown data
A disruption of the β2 RRQR ER retention/retrieval signal increased the proportion of nAChRs at the PM.
“A disruption of the β2 RRQR ER retention/retrieval signal increased the proportion of nAChRs at the PM (Fig. 3 B), and alterations of LFM motifs in α4 and β2 increased the surface expression of α4β2 receptors monotonically with the number of LFM motifs present in the receptor pentamer (Fig. 4, A–D).”
Quote in the paperSubstantial claim - Findingown data
The number of ERES per cell increased monotonically with the number of LFM motifs present in the receptor pentamer.
“In our observations with Sec24D-mcherry, the number of ERES per cell increased monotonically with the number of LFM motifs present in the receptor pentamer (Fig. 6 C).”
- Also stated in: § The control of ERES numbers · plain
“Indeed, we found that the number of ERES per cell increased monotonically with the number of LFM motifs present in the receptor pentamer (Fig. 6 C).”
Quote in the paperSubstantial claim - Also stated in: § The control of ERES numbers · plain
- Findingown data
Treatment with nicotine caused only a small increase in the PM level of double-mutant β2 subunits.
“These nicotine and double mutation effects approached a common maximum; treatment with nicotine caused only a small increase in the PM level of double-mutant β2 subunits (Fig. 2, B and C).”
Quote in the paperSubstantial claim - Findingown data
These nicotine and double mutation effects approached a common maximum.
“These nicotine and double mutation effects approached a common maximum; treatment with nicotine caused only a small increase in the PM level of double-mutant β2 subunits (Fig. 2, B and C).”
Quote in the paperSubstantial claim - Findingown data
Mutation of the β2 M3-M4 loop RRQR to AAQA resulted in markedly increased ER export and membrane-localized receptors versus wt nAChRs.
“In our studies, mutation of the β2 M3–M4 loop RRQR to AAQA resulted in markedly increased ER export and membrane-localized receptors versus wt nAChRs.”
Quote in the paperSubstantial claim - Findingreasoning
The predicted fluorescence of wt PM up-regulated nAChRs is 0.83 times that of receptors in the absence of nicotine.
“SePhaChARNS 2.0 incorporates this change in stoichiometry: we calculate the predicted fluorescence of wt PM up-regulated nAChRs as 0.83 times that of receptors in the absence of nicotine.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The mutation-sensitive step in ER exit has a limited flux capacity, so its effective rate constant decreases with increasing numbers of nAChR molecules.
- The authors state this as an assumption: The pool of export machinery can be depleted.
- The authors state this as an assumption: Several dozen export machinery–nAChR complexes presumably form each ERES or transport vesicle.
- Rests on an assumption: Nicotine binds at the subunit interface and thereby aids nAChR assembly.
- The authors state this as an assumption: The anterograde rate k_Folded→Golgi is zero.
- The authors state this as an assumption: All other steps in SePhaChARNS 2.0 follow first-order unidirectional kinetics, governed by rate constants with dimensions of s−1, as in the FOLDEX model.
- The authors state this as an assumption: The simulations force all molecular concentrations to scale with that of C1 unfolded, the initial constant source of unassembled, unfolded subunits.
- The authors state this as an assumption: The effect of nicotine is formalized as a binding step that helps nAChRs fold and assemble fully.
- The authors state this as an assumption: If further saturable steps do not occur, step 8 would govern the dose–response relation for up-regulation.
- Findingown data
ERES formation (step 9) proceeds greater than twofold more efficiently for α4β2 nAChRs containing the enhanced ER export mutant β2 subunit than for nAChRs containing wt β2 subunits.
“In particular, the simulations verified that ERES formation (step 9) proceeds greater than twofold more efficiently, and COPI-mediated retrieval (step 23) proceeds greater than twofold less rapidly, for α4β2 nAChRs containing the enhanced ER export mutant β2 subunit than for nAChRs containing wt β2 subunits (Tables II and III).”
Quote in the paperSubstantial claim - Findingown data
COPI-mediated retrieval (step 23) proceeds greater than twofold less rapidly for α4β2 nAChRs containing the enhanced ER export mutant β2 subunit than for nAChRs containing wt β2 subunits.
“In particular, the simulations verified that ERES formation (step 9) proceeds greater than twofold more efficiently, and COPI-mediated retrieval (step 23) proceeds greater than twofold less rapidly, for α4β2 nAChRs containing the enhanced ER export mutant β2 subunit than for nAChRs containing wt β2 subunits (Tables II and III).”
Quote in the paperSubstantial claim - Findingown data
The number of ERES increased in cells expressing α4-eGFPβ2-365AAQA368 nAChRs.
“We also observed an increase in the number of ERES in cells expressing α4-eGFPβ2-365AAQA368 nAChRs.”
Quote in the paperSubstantial claim - Findingown data
Nicotine increased the number of pixels in the ER category, as judged by α4-FP fluorescence.
“In an alternative analysis of the TIRF data, we did find that nicotine increased the number of pixels in the ER category, as judged by α4-FP fluorescence; but additional studies are required to gauge the generality of this finding.”
Quote in the paperNot a substantial claim - Findingown data
Both (α4)2(β2)3 and (α4)3(β2)2 stoichiometries traffic to the trans-Golgi.
“First, our NFRET experiments showed that wt α4β2 receptors assemble with a roughly equal proportion of (α4)2(β2)3 and (α4)3(β2)2 stoichiometries in the ER, and that both stoichiometries traffic to the trans-Golgi (Fig. 5 B).”
Quote in the paperSubstantial claim - Findingown data
wt α4β2 receptors assemble with a roughly equal proportion of (α4)2(β2)3 and (α4)3(β2)2 stoichiometries in the ER.
“First, our NFRET experiments showed that wt α4β2 receptors assemble with a roughly equal proportion of (α4)2(β2)3 and (α4)3(β2)2 stoichiometries in the ER, and that both stoichiometries traffic to the trans-Golgi (Fig. 5 B).”
Quote in the paperSubstantial claim - Findingown data
Many-perhaps most-α4β2 nAChRs localize to the ER.
“Similarly, our pilot TIRFM experiments (presented in Materials and methods) showed that many—perhaps most—α4β2 nAChRs localize to the ER, but α4β4 nAChRs primarily localized to the PM (Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
Increasing the number of LFM motifs also biased the receptors toward the (α4)2(β2)3 stoichiometry.
“Reciprocally, increasing the number of LFM motifs also biased the receptors toward the (α4)2(β2)3 stoichiometry (Fig. 5 B and Table I); possibly, these Sec24D-binding sites allow Sec24D to stabilize this stoichiometry.”
Quote in the paperSubstantial claim - Findingown data
α4β4 nAChRs primarily localize to the PM.
“Similarly, our pilot TIRFM experiments (presented in Materials and methods) showed that many—perhaps most—α4β2 nAChRs localize to the ER, but α4β4 nAChRs primarily localized to the PM (Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
Nicotine treatment of wt α4β2-expressing cells increased the assembly of (α4)2(β2)3 nAChRs.
“Nicotine treatment of wt α4β2-expressing cells increased the assembly of (α4)2(β2)3 nAChRs (Fig. 5 B and Table I).”
Quote in the paperSubstantial claim - Findingown data
Satisfactory simulations were achieved if the effective endogenous nicotine concentration was ≤0.0033 μM (n ≥ 30).
“Satisfactory simulations were achieved if the “effective endogenous nicotine concentration” was ≤0.0033 µM (n ≥ 30), implying that nicotine incubation improves pharmacological chaperoning by ≥30-fold.”
Quote in the paperSubstantial claim - Findingown data
Alterations of LFM motifs in α4 and β2 increased the surface expression of α4β2 receptors monotonically with the number of LFM motifs present in the receptor pentamer.
“A disruption of the β2 RRQR ER retention/retrieval signal increased the proportion of nAChRs at the PM (Fig. 3 B), and alterations of LFM motifs in α4 and β2 increased the surface expression of α4β2 receptors monotonically with the number of LFM motifs present in the receptor pentamer (Fig. 4, A–D).”
Quote in the paperSubstantial claim - Findingown data
Mutant β2-L349M and β2-365AAQA368 subunits preferentially assembled nAChRs with (α4)2(β2)3 stoichiometry.
“Second, in contrast to wt receptors, mutant β2-L349M and β2-365AAQA368 subunits preferentially assembled nAChRs with (α4)2(β2)3 stoichiometry (Fig. 5 B and Table I).”
Quote in the paperSubstantial claim - Interpretationown data
Nicotine-induced up-regulation takes place despite an overall bias toward ER-resident nAChRs.
“Evidently, up-regulation takes place despite an overall bias toward ER-resident nAChRs.”
Quote in the paperSubstantial claim - Interpretationreasoning
Pharmacological chaperoning of nAChRs by nicotine can alter the physiology of ER processes.
“The data also suggest that pharmacological chaperoning of nAChRs by nicotine can alter the physiology of ER processes.”
Quote in the paperSubstantial claim- The authors state this as an assumption: One or more mechanisms common to all cellular systems govern nicotine-induced nAChR up-regulation.
- Interpretationreasoning
Removal of the ER export bottleneck (e.g., by expression of the β2enhanced-ER-export subunit) is sufficient to increase PM nAChR numbers, even without nicotine.
“The experimental data are simulated with a model incorporating two mechanisms: (1) nicotine acts as a stabilizing pharmacological chaperone for nascent α4β2 nAChRs in the ER, eventually increasing PM receptors despite a bottleneck(s) in ER export; and (2) removal of the bottleneck (e.g., by expression of the β2enhanced-ER-export subunit) is sufficient to increase PM nAChR numbers, even without nic”
Quote in the paperSubstantial claim - Premisecitation
Chronic nicotine increases the number of neuronal nicotinic acetylcholine receptors (nAChRs).
“Literature since 1983 also shows that chronic nicotine increases the number of neuronal nicotinic acetylcholine receptors (nAChRs) (Marks et al., 1983; Schwartz and Kellar, 1983).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Nicotine enhances the assembly of functional nAChRs containing the α4 and β2 subunits.
“Data from such favorable systems show that nicotine enhances the assembly of functional nAChRs containing the α4 and β2 subunits and also causes the preferential assembly of receptors with (α4)2(β2)3 stoichiometry (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Nicotine-induced up-regulation of nAChRs has been replicated in systems ranging from clonal cell lines to primary neurons in culture, mouse models, and smokers' brains.
“Nicotine-induced “up-regulation” has been replicated many times in systems ranging from clonal cell lines to primary neurons in culture, to mouse models, and to smokers’ brains (Breese et al., 1997; Court et al., 1998; Staley et al., 2006; Mukhin et al., 2008; Albuquerque et al., 2009; Lester et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Nicotine causes the preferential assembly of receptors with (α4)2(β2)3 stoichiometry.
“Data from such favorable systems show that nicotine enhances the assembly of functional nAChRs containing the α4 and β2 subunits and also causes the preferential assembly of receptors with (α4)2(β2)3 stoichiometry (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
β subunits partially control the subcellular localization and trafficking of α4β2 and α4β4 nAChRs.
“Collectively, these data provide evidence that α4β2 nAChRs primarily localize to the ER, and that β subunits partially control the subcellular localization and trafficking of α4β2 and α4β4 nAChRs, explaining many previous studies in which α4β4 nAChRs show better surface expression than α4β2.”
Quote in the paperSubstantial claim - Premisecitation
nAChR mRNA levels remain constant after nicotine exposure.
“Moreover, nAChR mRNA levels remain constant after nicotine exposure (Marks et al., 1992; Peng et al., 1994; Ke et al., 1998).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
Nicotine acts as a stabilizing pharmacological chaperone for nascent α4β2 nAChRs in the ER, eventually increasing PM receptors despite a bottleneck(s) in ER export.
“The experimental data are simulated with a model incorporating two mechanisms: (1) nicotine acts as a stabilizing pharmacological chaperone for nascent α4β2 nAChRs in the ER, eventually increasing PM receptors despite a bottleneck(s) in ER export; and (2) removal of the bottleneck (e.g., by expression of the β2enhanced-ER-export subunit) is sufficient to increase PM nAChR numbers, even without nic”
Quote in the paperSubstantial claim- The authors state this as an assumption: One or more mechanisms common to all cellular systems govern nicotine-induced nAChR up-regulation.
- Interpretationown data
Nicotine causes an increase in the proportion of nAChRs localized in the ER.
“indicating that nicotine also caused an increase in the proportion of nAChRs localized in the ER.”
Quote in the paperSubstantial claim - Interpretationreasoning
The result of this mechanism is that nAChRs reach the PM in greater numbers.
“The data strongly support the following mechanism: the (α4)2(β2)3 stoichiometry would languish in the ER, but nicotine acts as a pharmacological chaperone to stabilize (α4)2(β2)3 nAChRs and presumably, as a consequence, ERES. The result: nAChRs reach the PM in greater numbers.”
Quote in the paperSubstantial claim- The authors state this as an assumption: One or more mechanisms common to all cellular systems govern nicotine-induced nAChR up-regulation.
- Interpretationown data
Enhanced ER export β2 double-mutant subunits produce nearly maximal anterograde trafficking of nAChRs even in the absence of nicotine.
“suggesting that enhanced ER export β2 double-mutant subunits produced nearly maximal anterograde trafficking of nAChRs, even in the absence of nicotine.”
Quote in the paperSubstantial claim - Interpretationreasoning
The point mutations α4L358A and β2-L349M enable expression of receptor combinations containing zero, two to three, or five LFM motifs.
“We reasoned that these point mutations enabled the expression of specific receptor combinations containing (a) zero LFM motifs (α4L358A-eGFP plus β2wt), (b) two to three LFM motifs (α4-eGFP plus β2wt), or (c) five LFM motifs (α4-eGFP plus β2-L349M).”
Quote in the paperSubstantial claim - Premiseown data
The lower and higher NFRET components represent the (α4)2(β2)3 and (α4)3(β2)2 nAChR stoichiometries, respectively.
“Our analysis, summarized in Table I, used the parameters A1 and A2 that correspond to the total pixels contributing to lower and higher NFRET components, which represent the (α4)2(β2)3 and (α4)3(β2)2 nAChR stoichiometries, respectively.”
Quote in the paperSubstantial claim - Interpretationown data
Wild-type and mutant α4β2 nAChRs assemble with both (α4)2(β2)3 and (α4)3(β2)2 stoichiometries in the ER.
“Collectively, NFRET analyses show that wt and mutant α4β2 nAChRs assemble with both (α4)2(β2)3 and (α4)3(β2)2 stoichiometries in the ER.”
Quote in the paperSubstantial claim - Premisecitation
Chronic nicotine exposure shifts nAChR stoichiometry from approximately equal contributions of the two stoichiometries in nicotine-naive cells to ∼100% (α4)2(β2)3.
“In fact, our experiments and previous data (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009) suggest a shift from approximately equal contributions of the two stoichiometries in nicotine-naive cells to ∼100% (α4)2(β2)3 after chronic nicotine exposure.”
Quote in the paperSubstantial claim0 of 3 sources checked - Study design and conductcitation
Pixel-based NFRET is an appropriate method to determine the stoichiometry of protein complexes in Neuro-2a cells.
“Pixel-based NFRET is an appropriate method to determine the stoichiometry of protein complexes in Neuro-2a cells (Moss et al., 2009; Son et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Endogenous α4β2 nAChRs localize at least partially to the smooth ER in mouse dorsal raphe and rat cortical neurons.
“Electron microscopy studies in mouse dorsal raphe and rat cortical neurons show that endogenous α4β2 nAChRs localize at least partially to the smooth ER (Hill et al., 1993; Commons, 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data
This study reveals two processes within the ER and TG/TGN that bias the α4β2 nAChR population toward the (α4)2(β2)3 stoichiometry.
“This study reveals two processes within the ER and TG/TGN that bias the α4β2 nAChR population toward the (α4)2(β2)3 stoichiometry.”
Quote in the paperSubstantial claim - Interpretationreasoning
Nicotine provides a pharmacological chaperoning effect within the ER, upstream from a flux-limited ER export process.
“The model is consistent with the idea that nicotine provides a pharmacological chaperoning effect within the ER, upstream from a flux-limited ER export process, and that this ER export limitation is ameliorated by the (perhaps tautologically named) enhanced ER export β2 subunit mutant.”
Quote in the paperSubstantial claim - Premisecitation
Previous results based on glycosylation and molecular weight measures show that up-regulation is initiated in the ER.
“These data correspond with previous results based on glycosylation and molecular weight measures, showing that up-regulation is initiated in the ER (Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
RXR motifs enhance the ER localization of ion channels.
“RXR motifs enhance the ER localization of ion channels (Scott et al., 2003; Gassmann et al., 2005).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
α4β2 nAChRs possess ER export motifs recognizing Sec24A and Sec24D molecules.
“The available data thus show that α4β2 nAChRs possess ER export motifs recognizing Sec24A and Sec24D molecules.”
Quote in the paperSubstantial claim - Interpretationreasoning
The model requires no flux-limited steps that occur after ER export.
“The model requires no flux-limited steps that occur after ER export.”
Quote in the paperSubstantial claim - Premisecitation
Previous measurements have detected no differences between FP-labeled and unlabeled wt α4 subunits.
“We cannot state that the FP-labeled subunits perfectly emulate the unlabeled subunit, but our previous measurements have detected no differences between the FP-labeled and unlabeled wt α4 subunits.”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
The chaperoning effect of nicotine enhances an endogenous process by a factor (n) between 10 and 30.
“The chaperoning effect of nicotine appears to enhance an endogenous process by a factor (n) between 10 and 30.”
Quote in the paperSubstantial claim - Interpretationown data
Nicotine-induced changes in nAChR stoichiometry are initiated in the ER.
“We know that nicotine-induced changes in nAChR stoichiometry are initiated in the ER, because in nicotine-treated cells, the TG/TGN contained mostly (α4)2(β2)3 receptors (Fig. 5 B and Table I).”
Quote in the paperSubstantial claim - Interpretationreasoning
Nicotine incubation improves pharmacological chaperoning by ≥30-fold.
“Satisfactory simulations were achieved if the “effective endogenous nicotine concentration” was ≤0.0033 µM (n ≥ 30), implying that nicotine incubation improves pharmacological chaperoning by ≥30-fold.”
Quote in the paperNot a substantial claim - Interpretationown data
The recruitment of ERES depends directly on ER export efficiency.
“Our observation that ERES numbers increase—even without nicotine—for enhanced ER export of nAChRs shows that the recruitment of ERES depends directly on ER export efficiency and extends previous observations that simple coexpression of membrane proteins can enhance ERES number (Farhan et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Farhan et al., 2008 source
Not checked in the free run.
- Interpretationown data
The enhancement of ERES depends not merely on the presence of a cargo protein but also on the interaction between an intracellular ligand and a cargo protein (nicotine-nAChR).
“Our experiments go further by showing that the enhancement depends not merely on the presence of a cargo protein but also on the interaction between an intracellular ligand and a cargo protein (nicotine–nAChR).”
Quote in the paperSubstantial claim - Interpretationreasoning
Human and chicken receptors might exit the ER more efficiently than mouse and rat receptors.
“Thus, our data suggest that human and chicken receptors might exit the ER more efficiently than mouse and rat receptors, but human and chicken receptors also harbor the RRQR motif and would therefore still be up-regulated by chronic nicotine.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The ER export limitation is ameliorated by the enhanced ER export β2 subunit mutant.
“The model is consistent with the idea that nicotine provides a pharmacological chaperoning effect within the ER, upstream from a flux-limited ER export process, and that this ER export limitation is ameliorated by the (perhaps tautologically named) enhanced ER export β2 subunit mutant.”
Quote in the paperSubstantial claim - Interpretationown data
The SePhaChARNS 2.0 model provides a reasonable explanation for most of the differential effects of nicotine incubation and of the enhanced ER export β2 subunit.
“The SePhaChARNS 2.0 model therefore provides a reasonable explanation for most of the differential effects of nicotine incubation and of the enhanced ER export β2 subunit.”
Quote in the paperSubstantial claim - Interpretationown data
The nicotine-nAChR complex produces noticeable redistribution of at least one other ER protein.
“The nicotine–nAChR complex thus produces noticeable redistribution of at least one other ER protein, which is remarkable even if one does not consider eventual up-regulation at the PM.”
Quote in the paperSubstantial claim - Interpretationreasoning
Enhanced ER export mutant β2 subunits alter this balance in favor of PM localization.
“Enhanced ER export mutant β2 subunits alter this balance in favor of PM localization.”
Quote in the paperSubstantial claim - Interpretationreasoning
Trafficking and stoichiometry influence each other.
“The present subcellularly resolved imaging data agree with the views that the mechanisms of α4β2 nAChR trafficking depend on the balance between ER export and retention/retrieval motifs in α4β2 pentamers; that this balance depends in part on the stoichiometry of α4β2 nAChRs; that trafficking and stoichiometry influence each other; and that a sustained interaction between nicotine and nAChRs exerts”
Quote in the paperSubstantial claim - Interpretationown data
The mechanisms of α4β2 nAChR trafficking depend on the balance between ER export and retention/retrieval motifs in α4β2 pentamers.
“The present subcellularly resolved imaging data agree with the views that the mechanisms of α4β2 nAChR trafficking depend on the balance between ER export and retention/retrieval motifs in α4β2 pentamers; that this balance depends in part on the stoichiometry of α4β2 nAChRs; that trafficking and stoichiometry influence each other; and that a sustained interaction between nicotine and nAChRs exerts”
Quote in the paperSubstantial claim - Premisecitation
Nicotine concentrations are elevated within ERGIC, TG/TGN, and secretory vesicles via acid trapping.
“Nicotine concentrations are elevated within ERGIC, TG/TGN, and secretory vesicles via acid trapping (Lester et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lester et al., 2009 source
Not checked in the free run.
- Interpretationreasoning
(α4)2(β2)3 nAChRs with a 2:3 ratio of ER export to retention/retrieval motifs largely localize to the ER.
“wt (α4)3(β2)2 receptors contain a 3:2 ratio of LFM (ER export motifs) to RRQR (ER retention/retrieval) motifs and traffic efficiently to the PM, whereas (α4)2(β2)3 nAChRs with a 2:3 ratio of ER export to retention/retrieval motifs largely localize to the ER.”
Quote in the paperSubstantial claim - Interpretationcitation
The thermodynamic driving force for the stoichiometry shift is the tighter binding of nicotine to the (α4)2(β2)3 stoichiometry.
“The thermodynamic driving force for this stoichiometry shift is presumably the tighter binding of nicotine to the (α4)2(β2)3 stoichiometry (Nelson et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nelson et al., 2003 source
Not checked in the free run.
- Interpretationreasoning
For wt nAChRs, up-regulation at the PM appears to be limited by ER export.
“At present, however, the model satisfactorily accounts for the following ideas: (a) chaperoning by nicotine precedes export from the ER; (b) nicotine enhances an endogenous process by a factor of 10–30; (c) for wt nAChRs, up-regulation at the PM appears to be limited by ER export; and (d) up-regulation does not depend on flux limitations beyond ER export.”
Quote in the paperSubstantial claim - Interpretationown data
An overall increase of PM α4β2 nAChRs results from the stabilization of assembled receptors by nicotine.
“Our experiments also show that an overall increase of PM α4β2 nAChRs results from the stabilization of assembled receptors by nicotine.”
Quote in the paperSubstantial claim - Interpretationnone given
Chaperoning by nicotine precedes export from the ER.
“At present, however, the model satisfactorily accounts for the following ideas: (a) chaperoning by nicotine precedes export from the ER; (b) nicotine enhances an endogenous process by a factor of 10–30; (c) for wt nAChRs, up-regulation at the PM appears to be limited by ER export; and (d) up-regulation does not depend on flux limitations beyond ER export.”
Quote in the paperSubstantial claim - Interpretationreasoning
The effect of mutant β2-L349M and β2-365AAQA368 subunits on stoichiometry arises from a binding-stabilization mechanism between nAChRs and Sec24 proteins rather than between nAChRs and nicotine.
“We suggested above that this effect also arises from a binding–stabilization mechanism between nAChRs and Sec24 proteins rather than between nAChRs and nicotine.”
Quote in the paperSubstantial claim - Interpretationown data
This balance depends in part on the stoichiometry of α4β2 nAChRs.
“The present subcellularly resolved imaging data agree with the views that the mechanisms of α4β2 nAChR trafficking depend on the balance between ER export and retention/retrieval motifs in α4β2 pentamers; that this balance depends in part on the stoichiometry of α4β2 nAChRs; that trafficking and stoichiometry influence each other; and that a sustained interaction between nicotine and nAChRs exerts”
Quote in the paperSubstantial claim - Interpretationown data
A sustained interaction between nicotine and nAChRs exerts control over both trafficking and stoichiometry.
“The present subcellularly resolved imaging data agree with the views that the mechanisms of α4β2 nAChR trafficking depend on the balance between ER export and retention/retrieval motifs in α4β2 pentamers; that this balance depends in part on the stoichiometry of α4β2 nAChRs; that trafficking and stoichiometry influence each other; and that a sustained interaction between nicotine and nAChRs exerts”
Quote in the paperSubstantial claim - Interpretationreasoning
Up-regulation does not depend on flux limitations beyond ER export.
“At present, however, the model satisfactorily accounts for the following ideas: (a) chaperoning by nicotine precedes export from the ER; (b) nicotine enhances an endogenous process by a factor of 10–30; (c) for wt nAChRs, up-regulation at the PM appears to be limited by ER export; and (d) up-regulation does not depend on flux limitations beyond ER export.”
Quote in the paperSubstantial claim
- May combine two claims. 67
- Classified as probably not a substantial claim. 23
- The quote only partly states this claim. 2
May combine two claims.
Findingown dataThe ER fluorescence in α4eGFP plus β2wt-transfected cells was two- to threefold brighter than PM and displayed little to no vesicular dynamics.
“The ER fluorescence in α4eGFP plus β2wt–transfected cells was two- to threefold brighter than PM and displayed little to no vesicular dynamics (Video 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe vesicles in α4eGFP plus β4wt-transfected cells were pleomorphic, with diameters ranging from 0.5 to 1 μm, some elongated 2 to 5 μM, and either stationary or showing spatial displacements of 0.5-5 μm/s.
“Vesicles were pleomorphic, with diameters ranging from 0.5 to 1 µm. Some vesicles appeared as elongated structures ranging from 2 to 5 µM in length. Vesicles were either stationary or showed spatial displacements of 0.5–5 µm/s within the TIRF footprint.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe footprint/ER ratio was 1.69 for α4eGFP plus β2wt and 5.01 for α4eGFP plus β4wt-transfected cells, indicating an approximately threefold increase in ER-localized nAChRs for α4β2.
“Measured ratios revealed an approximately threefold increase in ER-localized nAChRs for α4eGFP plus β2wt (footprint/ER ratio = 1.69) when compared with α4eGFP plus β4wt–transfected cells (footprint/ER ratio = 5.01; Fig. 1 D, 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataα4eGFP plus β4wt-transfected cells showed much less reticulate fluorescence and displayed vesicles within the TIRF footprint.
“In contrast, α4eGFP plus β4wt–transfected cells showed much less reticulate fluorescence, but these cells also displayed vesicles within the TIRF footprint (Video 2).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Findingnone givenThe β2enhanced-ER-export mutant subunit mimics two regions of the β4 subunit sequence: the presence of an ER export motif and the absence of an ER retention/retrieval motif.
“To aid in the mechanistic analysis of these phenomena, we generated a β2enhanced-ER-export mutant subunit that mimics two regions of the β4 subunit sequence: the presence of an ER export motif and the absence of an ER retention/retrieval motif.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn control solutions, the footprint/ER ratio for wild-type nAChRs was 3.42; nicotine treatment reduced the footprint/ER ratio to 2.19.
“In control solutions, the footprint/ER ratio was 3.42; nicotine treatment reduced the footprint/ER ratio to 2.19.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeuro-2a cells expressing α4-eGFPβ2-365AAQA368 nAChRs show an increase in the number of PM-localized pixels, an effect enhanced after treatment with 0.1 μM nicotine for 48 h.
“Neuro-2a cells expressing α4-eGFPβ2-365AAQA368 nAChRs showed an increase in the number of PM-localized pixels, an effect that was enhanced after treatment with 0.1 µM nicotine for 48 h.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTwo ER fluorescence peaks are observed in Fig. 1 D (1).
“Two ER fluorescence peaks are observed in Fig. 1 D (1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe footprint/ER ratio for α4-eGFPβ2-L349M is 2.09, a 1.25-fold increase over α4-eGFPβ2wt (1.69), whereas α4L358A-eGFPβ2wt-transfected cells show a small reduction (1.43).
“Results showed a 1.25-fold increase in the ratio of α4-eGFPβ2-L349M (footprint/ER ratio = 2.09) as compared with α4-eGFPβ2wt nAChRs (footprint/ER ratio = 1.69), whereas α4L358A-eGFPβ2wt–transfected cells showed a small reduction in the integrated density ratio (footprint/ER ratio = 1.43).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Findingown dataPM-localized pCS2-mcherry fluorescence was detected as a cellular footprint with uniform fluorescence, whereas ER-Tracker Green exhibited a reticulate pattern.
“PM-localized pCS2-mcherry fluorescence was detected as a cellular footprint with uniform fluorescence, whereas ER-Tracker Green exhibited a reticulate pattern (Fig. 1 A, first and third columns).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataReceptors in ∼90% of α4L358A-eGFPβ2wt-transfected cells primarily localize to the ER, and the remaining 10% of cells do not yield clear TIRF footprints.
“In contrast, receptors in ∼90% of α4L358A-eGFPβ2wt–transfected cells primarily localized to the ER (Fig. 4 A, fourth column), and the remaining 10% of cells did not yield clear TIRF footprints.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingown dataMerged images showed that the ER fluorescence was readily distinguishable from PM-localized mcherry.
“Merged images showed that the ER fluorescence was readily distinguishable from PM-localized mcherry (Fig. 1 A, first column).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe footprint/ER ratio for α4-eGFPβ2wt-transfected cells is 3.42, and nicotine treatment reduces it to 2.19.
“the footprint/ER ratio for α4-eGFPβ2wt transfected cells was 3.42, and nicotine treatment reduced the footprint/ER ratio to 2.19”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHuman and chicken β2 subunits possess an intact LFM motif, whereas chicken β2 subunits contain an RQTQ sequence in place of the RRQR motif.
“A cross-species comparison of mouse, human, and chicken β2 subunit sequences shows that, unlike mouse subunits, human and chicken β2 subunits possess an intact LFM motif, whereas chicken β2 subunits contain an RQTQ sequence in place of the RRQR motif (Fig. 2 D, 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe mouse β4 M3-M4 large intracellular loop contains an LFM motif (amino acids 344-346), whereas mouse β2 subunits possess a leucine residue at position 349, resulting in an LFL sequence at the aligning positions.
“Sequence alignments showed that the mouse β4 M3–M4 large intracellular loop contains an LFM motif (amino acids 344–346), whereas mouse β2 subunits possess a leucine residue at position 349, resulting in an LFL sequence at the aligning positions (Fig. 2 D, 1).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe β2 and β4 subunit sequences are strikingly similar in all other regions.
“The β2 and β4 sequences are strikingly similar in all other regions.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe footprint/ER ratio for α4eGFPβ2 double-mutant nAChR-transfected cells is 8.18, a 2.4-fold increase over α4eGFPβ2wt-transfected cells.
“The footprint/ER ratio for α4eGFPβ2 double-mutant nAChR-transfected cells was 8.18, a 2.4-fold increase over the ratio observed for α4eGFPβ2wt-transfected cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCompared with wild-type receptors, α4-eGFPβ2-365AAQA368 nAChRs show a 1.74-fold increase in PM intensity, almost equivalent to that observed for nicotine-treated α4-eGFPβ2wt nAChRs.
“When compared with wt receptors, α4-eGFPβ2-365AAQA368 nAChRs showed a 1.74-fold increase in the PM intensity, almost equivalent to that observed for nicotine-treated α4-eGFPβ2wt nAChRs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUnlike wild-type α4eGFPβ2 nAChRs, which show little or no vesicular dynamics, α4eGFPβ2-enhanced ER export double-mutant receptors display many 0.5-1-μM vesicles trafficking within the TIRFM footprint.
“Unlike wt α4eGFPβ2 nAChRs, which showed little or no vesicular dynamics (Video 1), α4eGFPβ2-enhanced ER export double-mutant receptors displayed many 0.5–1-µM vesicles trafficking within the TIRFM footprint (Video 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataβ2-365AAQA368 subunits increase PM localization of nAChRs, and this effect is enhanced after exposure to nicotine.
“β2-365AAQA368 subunits increased PM localization of nAChRs, and this effect was enhanced after exposure to nicotine.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data50% of α4-eGFPβ2-L349M-transfected cells show mixed ER plus PM localization, and the remaining 50% show TG/TGN- and PM-localized nAChRs.
“50% of α4-eGFPβ2-L349M–transfected cells showed a mixed ER plus PM localization, and the remaining 50% showed TG/TGN- and PM-localized nAChRs (Fig. 4 A, second and third columns).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe footprint/ER ratio for α4-eGFPβ2wt-transfected cells is 3.42, whereas nicotine treatment causes a significant reduction in peripheral ER pixels of α4-eGFPβ2wt receptors (footprint/ER ratio = 2.19).
“The footprint/ER ratio for α4-eGFPβ2wt–transfected cells was 3.42, whereas nicotine treatment caused a significant reduction in the peripheral ER pixels of α4-eGFPβ2wt receptors (footprint/ER ratio = 2.19).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataα4β2 nAChRs containing the β2-enhanced-ER-export double-mutant subunit localize strongly to the plasma membrane even in the absence of nicotine, and nicotine produces only a modest further up-regulation at the plasma membrane.
“The α4β2enhanced-ER-export nAChRs localize strongly to the PM, even in the absence of nicotine; nicotine produces only a modest further up-regulation at the PM.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCompared with non-nicotine-treated wt α4-eGFPβ2 nAChRs, the PM fraction of α4-eGFPβ2-365AAQA368 receptors is increased by 2.4-fold (footprint/ER ratio = 5.33), whereas nicotine treatment results in a further 1.6-fold increase (footprint/ER ratio = 8.53).
“When compared with non-nicotine–treated wt α4-eGFPβ2 nAChRs, the PM fraction of α4-eGFPβ2-365AAQA368 receptors was increased by 2.4-fold (footprint/ER ratio = 5.33), whereas nicotine treatment resulted in a further 1.6-fold increase in PM-localized α4-eGFPβ2-365AAQA368 receptors (footprint/ER ratio = 8.53).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataα4-eGFPβ2-L349M nAChRs show a 1.9-fold increase in PM-integrated density over α4-eGFPβ2wt nAChRs, whereas α4L358A-eGFPβ2wt nAChRs show a 2.9-fold reduction in PM-integrated density compared with α4-eGFPβ2wt nAChRs.
“The α4-eGFPβ2-L349M nAChRs showed a 1.9-fold increase in the PM-integrated density over α4-eGFPβ2wt nAChRs, whereas α4L358A-eGFPβ2wt nAChRs showed a 2.9-fold reduction in PM-integrated density when compared with α4-eGFPβ2wt nAChRs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThese motifs modulate the stoichiometry and ER exit of α4β2 nAChRs.
“Furthermore, we identify novel motifs governing the ER localization of α4β2 nAChRs within the β2 subunit M3–M4 large intracellular loop and show that these motifs modulate the stoichiometry and ER exit of α4β2 nAChRs.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningThe β2-enhanced-ER-export double-mutant subunit contains a disrupted ER retention motif (AAQA) and a reconstituted ER export motif (LFM).
“the “enhanced ER export” mouse β2 double-mutant subunit (β2-365AAQA368 L349M) contains a disrupted ER retention motif (AAQA) and a reconstituted ER export motif (LFM).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the TG/TGN, A1/(A1 + A2) is 0.36 for α4β2wt, whereas α4β2-L349M and α4β2-365AAQA368 nAChRs yield 0.69 and 0.73, respectively.
“As noted above, in the TG/TGN, we observed A1/(A1 + A2) = 0.36 for α4β2wt; on the other hand, α4β2-L349M and α4β2-365AAQA368 nAChRs yielded 0.69 and 0.73, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataα4-eGFPβ2-365AAQA368-transfected cells show an average of ∼38 ERES per cell, significantly higher than α4-eGFPβ2wt-transfected cells (∼20 ERES per cell; P < 0.01).
“In parallel experiments, quantification of ERES number in α4-eGFPβ2-365AAQA368–transfected cells showed an average of ∼38 ERES per cell, which was significantly higher than α4-eGFPβ2wt–transfected cells (∼20 ERES per cell; P < 0.01; Fig. 6 D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datanAChRs appear near ERES and move near, through, or past ERES.
“nAChRs do appear near ERES; furthermore, nAChRs seem to move near and, in some cases, through ERES or past ERES (Video 4).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningThe time scale of the calculations is determined primarily by the rates of insertion and removal from the surface PM, k_Golgi→PM and k_S→L.
“The time scale of the calculations is determined primarily by the rates of insertion and removal from the surface PM, k_Golgi→PM and k_S→L.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The mutation-sensitive step in ER exit has a limited flux capacity, so its effective rate constant decreases with increasing numbers of nAChR molecules.
- The authors state this as an assumption: The pool of export machinery can be depleted.
- The authors state this as an assumption: Several dozen export machinery–nAChR complexes presumably form each ERES or transport vesicle.
- Rests on an assumption: Nicotine binds at the subunit interface and thereby aids nAChR assembly.
- The authors state this as an assumption: The anterograde rate k_Folded→Golgi is zero.
- The authors state this as an assumption: All other steps in SePhaChARNS 2.0 follow first-order unidirectional kinetics, governed by rate constants with dimensions of s−1, as in the FOLDEX model.
- The authors state this as an assumption: The simulations force all molecular concentrations to scale with that of C1 unfolded, the initial constant source of unassembled, unfolded subunits.
- The authors state this as an assumption: The effect of nicotine is formalized as a binding step that helps nAChRs fold and assemble fully.
- The authors state this as an assumption: If further saturable steps do not occur, step 8 would govern the dose–response relation for up-regulation.
May combine two claims.
Findingown dataA1/(A1 + A2) for α4β2-L349M and α4β2-365AAQA368 receptors are greater (0.70 and 0.63, respectively) than for α4β2wt, indicating an increased proportion of nAChRs possessing (α4)2(β2-L349M)3 and (α4)2(β2-365AAQA368)3 stoichiometry.
“However A1/(A1 + A2) for α4β2-L349M and α4β2-365AAQA368 receptors were greater (0.70 and 0.63, respectively), indicating an increased proportion of nAChRs possessing a (α4)2(β2-L349M)3 and (α4)2(β2-365AAQA368)3 stoichiometry.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn whole cell section ROI, nicotine increases A1/(A1 + A2) for (α4)2(β2-L349M)3 from 0.70 to 0.79 and for (α4)2(β2-365AAQA368)3 from 0.67 to 0.70.
“For (α4)2(β2-L349M)3 nAChR pixels, nicotine increased A1/(A1 + A2) from 0.70 to 0.79. The analogous effect for the (α4)2(β2-365AAQA368)3 nAChR pixels was a change from 0.67 to 0.70.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingnone givenThe exemplar parameters in Tables II and III provide a good fit to the six target measures.
“Tables II and III give the exemplar parameters that provide a good fit to the six target measures.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The mutation-sensitive step in ER exit has a limited flux capacity, so its effective rate constant decreases with increasing numbers of nAChR molecules.
- The authors state this as an assumption: The pool of export machinery can be depleted.
- The authors state this as an assumption: Several dozen export machinery–nAChR complexes presumably form each ERES or transport vesicle.
- Rests on an assumption: Nicotine binds at the subunit interface and thereby aids nAChR assembly.
- The authors state this as an assumption: The anterograde rate k_Folded→Golgi is zero.
- The authors state this as an assumption: All other steps in SePhaChARNS 2.0 follow first-order unidirectional kinetics, governed by rate constants with dimensions of s−1, as in the FOLDEX model.
- The authors state this as an assumption: The simulations force all molecular concentrations to scale with that of C1 unfolded, the initial constant source of unassembled, unfolded subunits.
- The authors state this as an assumption: The effect of nicotine is formalized as a binding step that helps nAChRs fold and assemble fully.
- The authors state this as an assumption: If further saturable steps do not occur, step 8 would govern the dose–response relation for up-regulation.
May combine two claims.
Findingown data∼17 ERES per cell are observed with α4L358A-eGFPβ2wt receptors, whereas α4-eGFPβ2wt receptors show ∼30 ERES per cell.
“∼17 ERES per cell were observed with α4L358A-eGFPβ2wt receptors, whereas α4-eGFPβ2wt receptors showed ∼30 ERES per cell.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth incubation in nicotine and specific trafficking motifs within the β2 M3-M4 loop can influence the subcellular localization and trafficking of assembled nAChRs.
“Our data show that both incubation in nicotine and specific trafficking motifs within the β2 M3–M4 loop can influence the subcellular localization and trafficking of assembled nAChRs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataα4-eGFPβ2-L349M receptors show ∼52 ERES per cell, significantly different from α4-eGFPβ2wt receptors (P < 0.001).
“α4-eGFPβ2-L349M receptors showed ∼52 ERES per cell, which was significantly different from α4-eGFPβ2wt receptors (two-tailed t test; P < 0.001).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIncubation in nicotine, or manipulation of ER export and ER retention/retrieval motifs in the M3-M4 loop of nAChRs, increases nAChR PM expression.
“Our TIRFM experiments show that incubation in nicotine, or manipulation of ER export and ER retention/retrieval motifs in the M3–M4 loop of nAChRs, increases nAChR PM expression.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn all cases, 48-h nicotine exposure increases the proportion of nAChRs with a (α4)2(β2)3 stoichiometry, most markedly with wt nAChRs.
“In all cases, 48-h nicotine exposure increased the proportion of nAChRs with a (α4)2(β2)3 stoichiometry. This increase was most marked with wt nAChRs, which show the weakest bias toward the (α4)2(β2)3 stoichiometry in the absence of nicotine”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCoexpression of Sec24D, even with wt nAChRs and in the absence of nicotine, produces additional dynamic features in the nAChR population, as though the addition of Sec24D increases the proportion of nAChRs exiting the ER.
“TIRF videos of Neuro-2a cells cotransfected with α4-mcherry plus β2wt plus Sec24D-eGFP showed that coexpression of Sec24D, even with wt nAChRs and in the absence of nicotine, produced additional dynamic features in the nAChR population, as though the addition of Sec24D increases the proportion of nAChRs exiting the ER.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Findingown dataIn the model, k_Golgi→PM is the slowest step (10−4 s−1) and governs the simulated time course of PM up-regulation.
“In our formulation, this is the slowest step (k_Golgi→PM = 10−4 s−1) and governs the simulated time course of PM up-regulation (shown in Fig. 7 B).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The mutation-sensitive step in ER exit has a limited flux capacity, so its effective rate constant decreases with increasing numbers of nAChR molecules.
- The authors state this as an assumption: The pool of export machinery can be depleted.
- The authors state this as an assumption: Several dozen export machinery–nAChR complexes presumably form each ERES or transport vesicle.
- Rests on an assumption: Nicotine binds at the subunit interface and thereby aids nAChR assembly.
- The authors state this as an assumption: The anterograde rate k_Folded→Golgi is zero.
- The authors state this as an assumption: All other steps in SePhaChARNS 2.0 follow first-order unidirectional kinetics, governed by rate constants with dimensions of s−1, as in the FOLDEX model.
- The authors state this as an assumption: The simulations force all molecular concentrations to scale with that of C1 unfolded, the initial constant source of unassembled, unfolded subunits.
- The authors state this as an assumption: The effect of nicotine is formalized as a binding step that helps nAChRs fold and assemble fully.
- The authors state this as an assumption: If further saturable steps do not occur, step 8 would govern the dose–response relation for up-regulation.
May combine two claims.
Findingown dataα4β2wt assembles as (α4)2(β2wt)3 and (α4)3(β2wt)2 receptors with a nearly equal proportion of pixels containing the two stoichiometries (A1/(A1 + A2) = 0.51).
“As noted above, α4β2wt assembled as (α4)2(β2wt)3 and (α4)3(β2wt)2 receptors, with a nearly equal proportion of pixels containing the two stoichiometries: A1/(A1 + A2) = 0.51.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHuman β2 subunits contain the LFM ER export motif as well as the RRQR motif.
“Interestingly, human β2 subunits contain the LFM ER export motif as well as the RRQR motif, whereas chicken α4β2 nAChRs contain the LFM motif but do not possess the RRQR motif (Fig. 2 D, 2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChicken α4β2 nAChRs contain the LFM motif but do not possess the RRQR motif.
“Interestingly, human β2 subunits contain the LFM ER export motif as well as the RRQR motif, whereas chicken α4β2 nAChRs contain the LFM motif but do not possess the RRQR motif (Fig. 2 D, 2).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataThe model was unsuccessful in simulating the observed 1.86-fold increase in ERES sites in the enhanced ER export β2 double mutant in the absence of nicotine, unless k_F→ERES for wt nAChR was ∼10-fold lower than the exemplar parameter value.
“Here, the model was unsuccessful, simulating the observed increase in ERES numbers only if k_F→ERES for the wt nAChR was ∼10-fold lower than the exemplar parameter value.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNicotine up-regulated PM α4β2-wt nAChRs, despite markedly increasing the proportion of ER-localized α4β2-wt nAChRs.
“TIRFM experiments recapitulated that nicotine up-regulated PM α4β2-wt nAChRs, despite markedly increasing the proportion of ER-localized α4β2-wt nAChRs (Fig. 2, B and C).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataWith n = 10, the simulations were marginally acceptable (sum of squared residuals = 0.0127, with all predicted values in error by <7% difference).
“With n = 10 (an endogenous “effective nicotine concentration” 10-fold lower that the experimental value of 0.1 µM), the simulations were marginally acceptable (sum of squared residuals = 0.0127, with all predicted values in error by <7% difference).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThe data argue against roles for Ca2+-induced second messenger signaling cascades and transcriptional processes in nicotine-induced nAChR up-regulation.
“These data argue against roles for Ca2+-induced second messenger signaling cascades and transcriptional processes in nicotine-induced nAChR up-regulation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRRQR motifs are thought to prevent the exit of cargo from the ER and may additionally function as ER retrieval motifs via the binding of the RRXR domain to COPI proteins.
“RRQR motifs are thought to prevent the exit of cargo from the ER and may additionally function as ER retrieval motifs via the binding of the RRXR domain to COPI proteins (Scott et al., 2001, 2003; Brock et al., 2005; Michelsen et al., 2005).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataLFM motifs in the M3-M4 loop of α4 and β2 subunits alter the ratio of receptors localized within the cellular PM versus the ER, and the PM nAChR number increases monotonically with the number of LFM export motifs present in receptor pentamers.
“Collectively, these results demonstrate that LFM motifs in the M3–M4 loop of α4 and β2 subunits alter the ratio of receptors localized within the cellular PM versus the ER, and that the PM nAChR number increases monotonically with the number of LFM export motifs present in receptor pentamers.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMutation of the β2 ER retention/retrieval motif interacts with nicotine treatment to further up-regulate nAChRs at the PM and increases the export of nAChRs from the ER, causing a net depletion of ER-localized receptors.
“Mutation of this motif interacts with nicotine treatment to further up-regulate nAChRs at the PM and increases the export of nAChRs from the ER, thus causing a net depletion of ER-localized receptors.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Study design and conductown dataThe TIRF data in Figs. 1-4 are robust to two alternative analyses: cell-by-cell calculations and pixel counting, yielding similar patterns and significance.
“Differences calculated with this method were also significant when the pixel-based analyses showed significance.”
- Also stated in: § Alternative analyses of the TIRFM data · plain
“Again, we found patterns similar to those of Figs. 1–4. Thus, the data of Figs. 1–4 satisfy two additional tests.”
Quote in the paperNot a substantial claim- Also stated in: § Alternative analyses of the TIRFM data · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe time scale (48 h) is relevant to the initial stages of nicotine-induced up-regulation in the brains of mice.
“The time scale is also relevant to the initial stages of nicotine-induced up-regulation in the brains of mice (Marks et al., 1985).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Marks et al., 1985 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe nicotine concentration used (0.1 μM) is somewhat less than that in the blood within a few minutes after a human smokes a cigarette and perhaps more appropriate to average values during a day of smoking.
“The experiments use a nicotine concentration (0.1 µM) somewhat less than that in the blood within a few min after a human smokes a cigarette, and perhaps more appropriate to the average values during a day of smoking (Matta et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matta et al., 2007 source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe β2 subunit possesses an ER export motif (LFM) and an ER retention/retrieval motif (RRQR) that can influence the anterograde trafficking of β2* nAChRs.
“the β2 subunit possesses an ER export motif (LFM) and an ER retention/retrieval motif (RRQR) that can influence the anterograde trafficking of β2* nAChRs”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataβ2-365AAQA368 subunits markedly increase the localization of receptors in the PM and reduce their localization in the ER, consistent with the presence of an ER retention/retrieval motif in the mouse β2 M3-M4 loop.
“These data show that β2-365AAQA368 subunits markedly increase the localization of receptors in the PM and reduce their localization in the ER, consistent with the presence of an ER retention/retrieval motif in the mouse β2 M3-M4 loop.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe data support the mechanism that (α4)2(β2)3 stoichiometry would languish in the ER, but nicotine acts as a pharmacological chaperone to stabilize (α4)2(β2)3 nAChRs and presumably, as a consequence, ERES.
“The data strongly support the following mechanism: the (α4)2(β2)3 stoichiometry would languish in the ER, but nicotine acts as a pharmacological chaperone to stabilize (α4)2(β2)3 nAChRs and presumably, as a consequence, ERES. The result: nAChRs reach the PM in greater numbers.”
Quote in the paperSubstantial claim- The authors state this as an assumption: One or more mechanisms common to all cellular systems govern nicotine-induced nAChR up-regulation.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationI/LXM-packaging motifs in ER cargo such as membrin and syntaxin 5 bind to a surface groove of Sec24D, a major component of COPII vesicles, and this binding partially enables packaging of ER cargo into COPII vesicles at ERES.
“Previous x-ray crystallographic and biochemical studies show that I/LXM (where X is any amino acid)-packaging motifs in ER cargo such as membrin and syntaxin 5 bind to a surface groove of Sec24D, which is a major component of COPII vesicles (Mancias and Goldberg, 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mancias and Goldberg, 2008
Not checked in the free run.
May combine two claims.
Study design and conductcitationUnder the transient transfection conditions used in Neuro-2a cells, membrane protein expression levels have not reached maximum, rendering the optical assays sensitive to mutations or pharmacological agents.
“Previous studies using both fluorescent gamma amino butyric acid transporters and fluorescent nAChRs established that, under the conditions used, membrane protein expression levels have not reached maximum (Drenan et al., 2008; Imoukhuede et al., 2009; Moss et al., 2009; Son et al., 2009).”
- Also stated in: § α4β2 nAChR up-regulation monitored optically · plain
“These conditions render the optical assays appropriately sensitive to mutations or pharmacological agents.”
Quote in the paperSubstantial claim0 of 3 sources checked- Also stated in: § α4β2 nAChR up-regulation monitored optically · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTIRFM enables the visualization of fluorescently labeled intracellular molecules within ∼300 nm of the cell-coverslip interface.
“TIRFM enables the visualization of fluorescently labeled intracellular molecules within ∼300 nm of the cell–coverslip interface (Oancea et al., 2006; Fish, 2009; Khiroug et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe ER forms the primary intracellular compartment of Neuro-2a cells.
“Our previous work used confocal microscopy to show that the ER forms the primary intracellular compartment of Neuro-2a cells (Moss et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Moss et al., 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNFRET could not be systematically studied in unlabeled COPI/COPII structures, peripheral trafficking vesicles, endosomes, and lysosomes.
“It has not been possible to systematically study NFRET in the additional structures present in our optical sections: unlabeled COPI/COPII structures, peripheral trafficking vesicles, endosomes, and lysosomes.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataBoth nAChR stoichiometries traffic to the TG/TGN, but nAChRs with the mutant β2 subunits studied here demonstrate a relatively high proportion of (α4)2(β2)3 nAChRs.
“Both nAChR stoichiometries traffic to the TG/TGN, but nAChRs with the mutant β2 subunits studied here demonstrate a relatively high proportion of (α4)2(β2)3 nAChRs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn cells expressing equal numbers of α4 subunits tagged with donor or acceptor FPs plus untagged β2 subunits, 50% of nAChRs with the (α4)3(β2)2 stoichiometry possess adjacent donor and acceptor α4-FP subunits, and these nAChRs show greater NFRET values than the (α4)2(β2)3 stoichiometry.
“Our previous work exploited the idea that in cells expressing equal numbers of α4 subunits tagged with donor or acceptor FPs (α4-FP subunits plus untagged β2 subunits), 50% of nAChRs with the (α4)3(β2)2 stoichiometry possess adjacent donor and acceptor α4-FP subunits. These nAChRs show greater NFRET values than the (α4)2(β2)3 nAChR stoichiometry, which has nonadjacent donors and acceptors (Son et”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Son et al., 2009 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationNicotine is thought to increase the assembly of receptors with a (α4)2(β2)3 stoichiometry.
“Because nicotine is thought to increase the assembly of receptors with a (α4)2(β2)3 stoichiometry (Nelson et al., 2003; Son et al., 2009)”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataTreatment with nicotine and mutations enhancing ER exit have similar effects of enhancing (α4)2(β2)3 stoichiometry, and these effects partially occlude each other, reaching a common maximal value in which 0.75-0.8 of the nAChRs possess the (α4)2(β2)3 stoichiometry.
“as though (a) treatment with nicotine and mutations enhancing ER exit have similar effects of enhancing (α4)2(β2)3 stoichiometry; and (b) these effects partially occlude each other, reaching a common maximal value in which 0.75–0.8 of the nAChRs possess the (α4)2(β2)3 stoichiometry.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenThe exemplar parameters are physically plausible and expected to fall within threefold of actual values.
“We consider these parameters physically plausible and expect that they fall within threefold of actual values.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The mutation-sensitive step in ER exit has a limited flux capacity, so its effective rate constant decreases with increasing numbers of nAChR molecules.
- The authors state this as an assumption: The pool of export machinery can be depleted.
- The authors state this as an assumption: Several dozen export machinery–nAChR complexes presumably form each ERES or transport vesicle.
- Rests on an assumption: Nicotine binds at the subunit interface and thereby aids nAChR assembly.
- The authors state this as an assumption: The anterograde rate k_Folded→Golgi is zero.
- The authors state this as an assumption: All other steps in SePhaChARNS 2.0 follow first-order unidirectional kinetics, governed by rate constants with dimensions of s−1, as in the FOLDEX model.
- The authors state this as an assumption: The simulations force all molecular concentrations to scale with that of C1 unfolded, the initial constant source of unassembled, unfolded subunits.
- The authors state this as an assumption: The effect of nicotine is formalized as a binding step that helps nAChRs fold and assemble fully.
- The authors state this as an assumption: If further saturable steps do not occur, step 8 would govern the dose–response relation for up-regulation.
May combine two claims.
PremisecitationSec24D binds to IXM motifs of vesicular proteins syntaxin 5 and membrin, so ERES formation is expected to increase with the number of Sec24D molecules recruited by LFM motifs within assembled nAChRs.
“Because a component of the COPII ERES complex, Sec24D, binds to IXM motifs of vesicular proteins syntaxin 5 and membrin (Mancias and Goldberg, 2008), one expects the formation of ERES to increase with the number of Sec24D molecules recruited by LFM motifs within assembled nAChRs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mancias and Goldberg, 2008
Not checked in the free run.
May combine two claims.
Interpretationown dataMutations in the M3-M4 loop of α4 and β2 subunits can influence ERES numbers and the rate of ER exit of nAChRs, either by affecting Sec24D binding to LFM motifs or by preventing ER retention through an RRQR motif in the mouse β2 M3-M4 loop.
“Collectively, these data show that mutations in the M3–M4 loop of α4 and β2 subunits can influence ERES numbers and the rate of ER exit of nAChRs, either by affecting Sec24D binding to LFM motifs or by preventing the ER retention of nAChRs through an RRQR motif in the mouse β2 M3–M4 loop.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIncreasing the number of Sec24-binding sites in the nAChR protein stabilizes a pentamer that binds Sec24D, and the Sec24D-containing ERES complex is in turn stabilized by binding to nAChR pentamers.
“Thus, increasing the number of Sec24-binding sites in the nAChR protein stabilizes a pentamer that binds Sec24D, and the Sec24D-containing ERES complex is in turn stabilized by binding to nAChR pentamers.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationER exit codes include LL motifs, bound by the Sec24A isoform, and I/LXM motifs, bound by Sec24D.
“ER exit codes include LL motifs, bound by the Sec24A isoform, and I/LXM motifs, bound by Sec24D (Wendeler et al., 2007; Mancias and Goldberg, 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Wendeler et al., 2007 source
Not checked in the free run.
- cites Mancias and Goldberg, 2008
Not checked in the free run.
May combine two claims.
InterpretationreasoningHuman and chicken receptors would still be up-regulated by chronic nicotine because they harbor the RRQR motif.
“Thus, our data suggest that human and chicken receptors might exit the ER more efficiently than mouse and rat receptors, but human and chicken receptors also harbor the RRQR motif and would therefore still be up-regulated by chronic nicotine.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationFour Sec24 isoforms (A, B, C, and D) recognize distinct ER exit codes in cargo proteins and participate in COPII vesicle assembly.
“Four Sec24 isoforms (A, B, C, and D) recognize distinct ER exit codes in cargo proteins and participate in COPII vesicle assembly (Russell and Stagg, 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Russell and Stagg, 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataAdditional mechanisms may be required to explain the 1.86-fold increased ERES sites in the enhanced ER export β2 double mutant in the absence of nicotine.
“The Discussion notes that additional mechanisms may be required to explain this datum.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningSec24D-binding sites allow Sec24D to stabilize the (α4)2(β2)3 stoichiometry.
“Reciprocally, increasing the number of LFM motifs also biased the receptors toward the (α4)2(β2)3 stoichiometry (Fig. 5 B and Table I); possibly, these Sec24D-binding sites allow Sec24D to stabilize this stoichiometry.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe β2-365AAQA368 mutation may increase ERES numbers by preventing the ER retention of assembled nAChRs and/or by decreasing the likelihood that COPII is displaced by a COPI-mediated ER retrieval of exported receptors.
“The β2-365AAQA368 mutation may increase ERES numbers by preventing the ER retention of assembled nAChRs and/or by decreasing the likelihood that COPII is displaced by a COPI-mediated ER retrieval of exported receptors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe LL ER export motifs were previously identified in the M3-M4 loop of nAChR subunits.
“The LL ER export motifs were previously identified in the M3–M4 loop of nAChR subunits (Ren et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ren et al., 2005 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe nicotine-favored state is both more capable of export and less susceptible to misfolding/degradation than other states within the ER.
“The key common concept is that the nicotine-favored state is both more capable of export and less susceptible to misfolding/degradation than other states within the ER.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningNewly assembled nicotine-bound nAChRs show increased ER exit; therefore, greater numbers of nAChRs undergo anterograde trafficking and insertion into the PM.
“Newly assembled nicotine-bound nAChRs show increased ER exit; therefore, greater numbers of nAChRs undergo anterograde trafficking and insertion into the PM.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenwt (α4)3(β2)2 receptors contain a 3:2 ratio of LFM (ER export motifs) to RRQR (ER retention/retrieval) motifs and traffic efficiently to the PM.
“wt (α4)3(β2)2 receptors contain a 3:2 ratio of LFM (ER export motifs) to RRQR (ER retention/retrieval) motifs and traffic efficiently to the PM, whereas (α4)2(β2)3 nAChRs with a 2:3 ratio of ER export to retention/retrieval motifs largely localize to the ER.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataNicotine enters the ER and stabilizes nAChRs with (α4)2(β2)3 stoichiometry.
“Nicotine enters the ER and stabilizes nAChRs with (α4)2(β2)3 stoichiometry (see Fig. 7; step 8).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningAt the PM, smoking-relevant nicotine concentrations only partially occupy nAChRs, revealing enhanced function of up-regulated α4β2 nAChRs.
“At the PM, smoking-relevant nicotine concentrations only partially occupy nAChRs, revealing enhanced function of up-regulated α4β2 nAChRs.”
Quote in the paperSubstantial claim
The authors state this as an assumption.
One or more mechanisms common to all cellular systems govern nicotine-induced nAChR up-regulation.
“One or more mechanisms common to all such cellular systems presumably govern up-regulation.”
The paper relies on this without support.
Up-regulation of α4β2* nAChRs by chronic nicotine is a cell-delimited process.
“The up-regulation of α4β2* nicotinic acetylcholine receptors (nAChRs) by chronic nicotine is a cell-delimited process and may be necessary and sufficient for the initial events of nicotine dependence.”
The paper relies on this without support.
Up-regulation of α4β2* nAChRs by chronic nicotine may be necessary and sufficient for the initial events of nicotine dependence.
“The up-regulation of α4β2* nicotinic acetylcholine receptors (nAChRs) by chronic nicotine is a cell-delimited process and may be necessary and sufficient for the initial events of nicotine dependence.”
The paper relies on this without support.
The ER displays a stacked tubular geometry.
“Because the ER displays a stacked tubular geometry, TIRF evanescent waves excite nAChRs localized at the PM as well as receptors located in the ER at increasing z distances from the cytoplasmic surface of the PM.”
The authors state this as an assumption.
The mutation-sensitive step in ER exit has a limited flux capacity, so its effective rate constant decreases with increasing numbers of nAChR molecules.
“The mutation-sensitive step in ER exit has a limited flux capacity in units of molecules/second; if expressed as a rate constant in units of s−1, the rate constant decreases with increasing numbers of nAChR molecules.”
The authors state this as an assumption.
The pool of export machinery can be depleted.
“Importantly for our formulation, this pool can be depleted.”
The authors state this as an assumption.
Several dozen export machinery–nAChR complexes presumably form each ERES or transport vesicle.
“The resulting complex condenses to form ERES (several dozen export machinery–nAChR complexes presumably form each ERES or transport vesicle) (Russell and Stagg, 2010).”
The paper relies on this without support.
Nicotine binds at the subunit interface and thereby aids nAChR assembly.
“Because nicotine binds at the subunit interface and therefore aids assembly, we depict nicotine as favoring the forward-folding step, rather than as inhibiting the unfolding”
The authors state this as an assumption.
The anterograde rate k_Folded→Golgi is zero.
“but to keep the model simple, we have set the anterograde rate, k_Folded→Golgi, equal to zero.”
The authors state this as an assumption.
All other steps in SePhaChARNS 2.0 follow first-order unidirectional kinetics, governed by rate constants with dimensions of s−1, as in the FOLDEX model.
“All other steps in SePhaChARNS 2.0 (Fig. 7 A) follow first-order unidirectional kinetics, governed by rate constants with the dimensions of s−1, as in the FOLDEX model (Wiseman et al., 2007).”
The authors state this as an assumption.
The simulations force all molecular concentrations to scale with that of C1 unfolded, the initial constant source of unassembled, unfolded subunits.
“The simulations force all molecular concentrations to scale with that of C1 unfolded, the initial constant source of unassembled, unfolded subunits.”
The authors state this as an assumption.
The effect of nicotine is formalized as a binding step that helps nAChRs fold and assemble fully.
“We formalized the effect of nicotine as a binding step that helps nAChRs fold and assemble fully (step 8).”
The authors state this as an assumption.
If further saturable steps do not occur, step 8 would govern the dose–response relation for up-regulation.
“If further saturable steps (similar to step 9) do not occur, step 8 would govern the dose–response relation for up-regulation.”
The authors state this as an assumption.
The cell is symmetric about a horizontal plane, and the simulated half is the one closest to the coverslip.
“Consider that the cell is symmetric about a horizontal plane and that we are simulating the half closest to the coverslip.”
The paper relies on this without support.
TIRFM fully visualizes the PM but only a fraction of internal membranes such as ER.
“TIRFM fully visualizes the PM but only a fraction of the internal membranes such as ER.”
The authors state this as an assumption.
Assembled nAChRs enter COPII-containing ERES.
“Assembled nAChRs presumably enter COPII-containing ERES.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Because β2-to-β4 replacement increases nAChR levels at the plasma membrane without nicotine, nicotine's proposed chaperoning function may be less effective.
“As replacement of β2 by β4 is sufficient to increase nAChR levels at the plasma membrane in the absence of nicotine, the proposed “chaperoning” function of nicotine might not be as effective (Srinivasan et al. 2011; Henderson et al. 2014).”
From Nicotine Withdrawal (2015) · cites this paper as Srinivasan et al. 2011
The TIRF microscopy section reports 1.9-fold higher plasma-membrane receptor density with β4 than with β2, supporting the first part of the claim. The Discussion says nicotine produced only a small further increase for an enhanced-export β2 mutant designed to mimic features of β4, but the paper does not establish that nicotine chaperoning is less effective for receptors containing β4 itself. No page numbers are available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The reported 2.4-fold PM-fraction increase does not match the ratios
MinorThe stated footprint/ER ratios are 5.33 for the mutant and 3.42 for wt. Their ratio is 1.56, not 2.4.
Reported 2.4 · recomputed 1.55848
“When compared with non-nicotine–treated wt α4-eGFPβ2 nAChRs, the PM fraction of α4-eGFPβ2-365AAQA368 receptors was increased by 2.4-fold (footprint/ER ratio = 5.33)”
A whole-cell NFRET fraction is printed as 73 rather than 0.73
MinorThe prose reports a change to 73, whereas Table I reports 0.73 for the same wt whole-cell nicotine condition. The quantity is defined as a fraction of pixels.
“from A1/(A1 + A2) = 0.51 to 73, in the whole cell section ROI.”
“| wt | 0.51 | vs. | 0.73 | 0.36 | vs. | 0.83 |”
The mutant's control whole-cell NFRET fraction disagrees with Table I
MinorFor β2-365AAQA368, the prose gives the control whole-cell fraction as 0.63, but Table I gives 0.67.
“A1/(A1 + A2) for α4β2-L349M and α4β2-365AAQA368 receptors were greater (0.70 and 0.63, respectively)”
“| 365AAQA368 | 0.67 | vs. | 0.70 | 0.63 | vs. | 0.74 |”
The paper both denies and asserts an RRQR motif in chicken β2
MinorThe Results identify RQTQ in chicken β2 in place of RRQR, but the Discussion says chicken receptors harbor RRQR.
“chicken β2 subunits contain an RQTQ sequence in place of the RRQR motif”
“human and chicken receptors also harbor the RRQR motif and would therefore still be up-regulated by chronic nicotine.”
ER pixels are said to decrease despite the reported PM and footprint/ER changes
MinorThe paper reports a 1.9-fold PM increase while the footprint/ER ratio falls from 3.42 to 2.19. Because the footprint comprises PM plus ER, those changes require ER signal to increase, not decrease; they imply an approximately 3.86-fold ER increase.
“The footprint/ER ratio for α4-eGFPβ2wt–transfected cells was 3.42, whereas nicotine treatment caused a significant reduction in the peripheral ER pixels of α4-eGFPβ2wt receptors (footprint/ER ratio = 2.19).”
“The PM up-regulation of wt nAChRs by nicotine, which amounts to 1.9-fold”
The mutant's control TG/TGN NFRET fraction disagrees with Table I
MinorThe prose assigns 0.73 to control α4β2-365AAQA368 in the TG/TGN, whereas Table I assigns it 0.63.
“in the TG/TGN, we observed A1/(A1 + A2) = 0.36 for α4β2wt; on the other hand, α4β2-L349M and α4β2-365AAQA368 nAChRs yielded 0.69 and 0.73, respectively.”
“| 365AAQA368 | 0.67 | vs. | 0.70 | 0.63 | vs. | 0.74 |”
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 11,816 · see citing works
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724 · see citing works
Synaptic plasticity and addiction
Kauer, J. A., & Malenka, R. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2234 · Cited by 1,397 · see citing works
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882 · see citing works
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · see citing works
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551 · see citing works
Diffusional Mobility of Golgi Proteins in Membranes of Living Cells
Cole, N. B., Smith, C. L., Sciaky, N., Terasaki, M., Edidin, M. A., & Lippincott‐Schwartz, J. (1996) · Science · doi:10.1126/science.273.5276.797 · Cited by 517 · see citing works
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479 · see citing works
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464 · see citing works
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422 · see citing works
An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing
Scott, D. B., Blanpied, T. A., Swanson, G. T., Zhang, C., & Ehlers, M. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03063.2001 · Cited by 418 · see citing works
Effect of smoking history on [3H]nicotine binding in human postmortem brain
Breese, C. R., Marks, M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C., & Leonard, S. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36798-9 · Cited by 396 · see citing works
Peng, X., Gerzanich, V, Anand, R., Whiting, P. J., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09730-5 · Cited by 391 · see citing works
Glutamate transmission in addiction
Kalivas, P. W., LaLumiere, R. T., Knackstedt, L. A., & Shen, H. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.011 · Cited by 389 · see citing works
Pooled analysis of tobacco use and risk of Parkinson disease.
Ritz, B., Ascherio, A., Checkoway, H., Marder, K., Nelson, L., Rocca, W., Ross, G., Strickland, D., den Eeden, S. K. V., & Gorell, J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.990 · Cited by 366 · see citing works
Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361 · see citing works
Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors
Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012419 · Cited by 275 · see citing works
Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2199-07.2007 · Cited by 274 · see citing works
Self-citationTime course study of the effects of chronic nicotine infusion on drug response and brain receptors
Marks, M. J., Stitzel, J. A., & Collins, A. C. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24213-6 · Cited by 265 · see citing works
Nicotine upregulates its own receptors through enhanced intracellular maturation
Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.029 · Cited by 261 · see citing works
Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow
Oancea, E., Wolfe, J. T., & Clapham, D. E. (2006) · Circulation Research · doi:10.1161/01.res.0000200179.29375.cc · Cited by 249 · see citing works
Michelsen, K., Yuan, H., & Schwappach, B. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400480 · Cited by 235 · see citing works
Total Internal Reflection Fluorescence (TIRF) Microscopy
Fish, K. N. (2009) · Current Protocols in Cytometry · doi:10.1002/0471142956.cy1218s50 · Cited by 228 · see citing works
Staley, J. K., Krishnan-Sarin, S., Cosgrove, K. P., Krantzler, E., Frohlich, E., Perry, E., Dubin, J. A., Estok, K., Brenner, E., Baldwin, R. M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0546-06.2006 · Cited by 223 · see citing works
Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit
Hill, J., Zoli, M., Bourgeois, J., & Changeux, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01551.1993 · Cited by 220 · see citing works
COPI-coated ER-to-Golgi transport complexes segregate from COPII in close proximity to ER exit sites
Stephens, D. J., Lin-Marq, N., Pagano, A., Pepperkok, R., & Paccaud, J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.12.2177 · Cited by 218 · see citing works
Structural basis of cargo membrane protein discrimination by the human COPII coat machinery
Mancias, J. D., & Goldberg, J. D. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.208 · Cited by 216 · see citing works
Feige, J. N., Sage, D., Wahli, W., Desvergne, B., & Gelman, L. (2005) · Microscopy Research and Technique · doi:10.1002/jemt.20215 · Cited by 215 · see citing works
Fenster, C. P., Whitworth, T. L., Sheffield, E. B., Quick, M. W., & Lester, R. A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04804.1999 · Cited by 204 · see citing works
Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
Vallejo, Y. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5240-04.2005 · Cited by 201 · see citing works
Role of Sec24 isoforms in selective export of membrane proteins from the endoplasmic reticulum
Wendeler, M. W., Paccaud, J., & Hauri, H. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7400893 · Cited by 197 · see citing works
Roles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195 · see citing works
Nashmi, R., Dickinson, M. E., McKinney, S., Jareb, M., Labarca, C., Fraser, S. E., & Lester, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11554.2003 · Cited by 188 · see citing works
Self-citationScott, D. B., Blanpied, T. A., & Ehlers, M. D. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00250-8 · Cited by 186 · see citing works
Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P., & Sullivan, J. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12264-7 · Cited by 178 · cited 1× · see citing works
“Other important mechanistic facts come from observations that nAChRs are also up-regulated by antagonists (Gopalakrishnan et al., 1996), and that drug–receptor binding plays a major role in up-regulation (Kishi and Steinbach, 2006).”
BackgroundLester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163 · see citing works
Self-citationAn Adaptable Standard for Protein Export from the Endoplasmic Reticulum
Wiseman, R. L., Powers, E. T., Buxbaum, J. N., Kelly, J. W., & Balch, W. E. (2007) · Cell · doi:10.1016/j.cell.2007.10.025 · Cited by 155 · see citing works
Pauly, J. R., Marks, M. J., Gross, S. D., & Collins, A. C. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20464-5 · Cited by 152 · see citing works
Whiteaker, P., Sharples, C. G. V., & Wonnacott, S. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13263-4 · Cited by 152 · see citing works
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056408 · Cited by 148 · see citing works
Whiteaker, P., Sharples, C. G., & Wonnacott, S. (1998) · PubMed · doi:10.7270/q2b856pt · Cited by 147 · see citing works
Adaptation of endoplasmic reticulum exit sites to acute and chronic increases in cargo load
Farhan, H., Weiss, M., Tani, K., Kaufman, R. J., & Hauri, H. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.136 · Cited by 138 · see citing works
Ke, L., Eisenhour, C. M., Bencherif, M., & Lukas, R. J. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37658-x · Cited by 136 · see citing works
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135 · see citing works
Mukhin, A. G., Kimes, A. S., Chefer, S. I., Matochik, J. A., Contoreggi, C. S., Horti, A. G., Vaupel, D. B., Pavlova, O., & Stein, E. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.050716 · Cited by 135 · see citing works
Slimko, E. M., McKinney, S. L., Anderson, D. J., Davidson, N., & Lester, H. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07373.2002 · Cited by 132 · see citing works
Self-citationDoura, M. B., Gold, A. B., Keller, A. B., & Perry, D. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.056 · Cited by 129 · see citing works
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 115 · see citing works
Self-citationNicotine regulates multiple synaptic proteins by inhibiting proteasomal activity
Rezvani, K., Teng, Y., Shim, D., & De Biasi, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3353-07.2007 · Cited by 113 · see citing works
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106 · see citing works
Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100 · see citing works
Self-citationBrock, C., Boudier, L., Maurel, D., Blahos, J., & Pin, J.-P. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-05-0400 · Cited by 81 · cited 1× · see citing works
“RRQR motifs are thought to prevent the exit of cargo from the ER and may additionally function as ER retrieval motifs via the binding of the RRXR domain to COPI proteins (Scott et al., 2001, 2003; Brock et al., 2005; Michelsen et al., 2005).”
BackgroundDarsow, T., Booker, T. K., Piña-Crespo, J. C., & Heinemann, S. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501157200 · Cited by 76 · see citing works
Harkness, P. C., & Millar, N. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10172.2002 · Cited by 74 · see citing works
Total Internal Reflection Fluorescence (TIRF) Microscopy
Trache, A., & Meininger, G. A. (2008) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc02a02s10 · Cited by 73 · see citing works
Kracun, S., Harkness, P. C., Gibb, A. J., & Millar, N. S. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707676 · Cited by 70 · see citing works
New Insights into the Structural Mechanisms of the COPII Coat
Russell, C., & Stagg, S. M. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.01026.x · Cited by 68 · see citing works
Nicotine Activates and Up-Regulates Nicotinic Acetylcholine Receptors in Bronchial Epithelial Cells
Fu, X. W., Lindstrom, J. M., & Spindel, E. R. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0352oc · Cited by 65 · see citing works
Schaub, B. E., Berger, B., Berger, E. G., & Rohrer, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0665 · Cited by 64 · see citing works
Structural determinants of α4β2 nicotinic acetylcholine receptor trafficking
Ren, X.-Q., Cheng, S.-B., Treuil, M. W., Mukherjee, J., Rao, J., Braunewell, K. H., Lindstrom, J. M., & Anand, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1079-05.2005 · Cited by 61 · see citing works
Son, C. D., Moss, F. J., Cohen, B. N., & Lester, H. A. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054494 · Cited by 58 · see citing works
Self-citationGassmann, M., Haller, C., Stoll, Y., Aziz, S. A., Biermann, B., Mosbacher, J., Kaupmann, K., & Bettler, B. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010256 · Cited by 56 · see citing works
Moss, F. J., Imoukhuede, P. I., Scott, K., Hu, J., Jankowsky, J. L., Quick, M. W., & Lester, H. A. (2009) · Journal of General Physiology · doi:10.1085/jgp.200910314 · Cited by 45 · see citing works
Self-citationA model for the self-organization of exit sites in the endoplasmic reticulum
Heinzer, S., Wörz, S., Kalla, C., Rohr, K., & Weiß, M. (2007) · Journal of Cell Science · doi:10.1242/jcs.013383 · Cited by 37 · see citing works
Pollock, V. V., Pastoor, T., Katnik, C., Cuevas, J., & Wecker, L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.032 · Cited by 31 · see citing works
Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic α4β2 Receptors
Kishi, M., & Steinbach, J. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029298 · Cited by 31 · see citing works
Imoukhuede, P. I., Moss, F. J., Michael, D. J., Chow, R. H., & Lester, H. A. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.11.070 · Cited by 29 · see citing works
Demonstration of functional α4-containing nicotinic receptors in the medial habenula
Fonck, C., Nashmi, R., Salas, R., Zhou, C., Huang, Q., Biasi, M. D., Lester, R. A. J., & Lester, H. A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.021 · Cited by 26 · see citing works
Self-citationNew dimensions in human laboratory models of addiction
Koob, G. F. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00127.x · Cited by 20 · see citing works
Khiroug, S. S., Pryazhnikov, E., Coleman, S. K., Jeromin, A., Keinänen, K., & Khiroug, L. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-141 · Cited by 19 · see citing works
Commons, K. G. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.056 · Cited by 17 · cited 3× · see citing works
“This agrees with previous observations (Hill et al., 1993; Commons, 2008).”
BackgroundResult
Flagged first, then by citations
3 of the 74 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 525 · see citing works
COPII and the regulation of protein sorting in mammals
Zanetti, G., Pahuja, K. B., Studer, S., Shim, S., & Schekman, R. W. (2011) · Nature Cell Biology · doi:10.1038/ncb2390 · Cited by 379 · see citing works
Structure and gating mechanism of the α7 nicotinic acetylcholine receptor
Noviello, C., Gharpure, A., Mukhtasimova, N., Cabuco, R., Baxter, L., Borek, D., Sine, S. M., & Hibbs, R. E. (2021) · Cell · doi:10.1016/j.cell.2021.02.049 · Cited by 303 · see citing works
Marinko, J. T., Huang, H., Penn, W. D., Capra, J. A., Schlebach, J. P., & Sanders, C. R. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00532 · Cited by 249 · see citing works
Ketamine: NMDA Receptors and Beyond
Zorumski, C. F., Izumi, Y., & Mennerick, S. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1547-16.2016 · Cited by 254 · see citing works
“In these organelles, ketamine could perhaps act as a chaperone for NMDARs or other receptors, as has been shown for nicotine at nicotinic receptors (Srinivasan et al., 2011).”
BackgroundNeural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Miwa, J. M., Freedman, R., & Lester, H. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.014 · Cited by 205 · see citing works
“The upregulation of α4β2* nAChRs by chronic nicotine treatment has been replicated many times in numerous systems—transfected cell lines, neurons in culture, brain slices, and smokers’ brains (Albuquerque et al., 2009; Fu et al., 2009; Lester et al., 2009; Srinivasan et al., 2011).”
InfluentialSelf-citationMcLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 173 · see citing works
An Optical Neuron-Astrocyte Proximity Assay at Synaptic Distance Scales
Octeau, J. C., Chai, H., Jiang, R., Bonanno, S. L., Martin, K. C., & Khakh, B. S. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.003 · Cited by 154 · see citing works
“The methods for pixel-by-pixel FRET from sensitized emission and donor dequenching have been described in detail (Moss et al., 2009; Richler et al., 2008; Son et al., 2009; Srinivasan et al., 2011).”
MethodMechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
“However, recent consensus of opinion, at least for upregulation of a4b2* nAChRs, has converged on the notion that nicotine acts as a pharmacological chaperone (Kuryatov et al., 2005; Henderson et al., 2014; Srinivasan et al., 2011, 2012).”
BackgroundShih, P.-Y., Engle, S. E., Oh, G., Deshpande, P., Puskar, N. L., Lester, H. A., & Drenan, R. M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0476-14.2014 · Cited by 136 · see citing works
“In contrast to 4 2* nAChRs, 4 4* nAChRs are not expected to undergo marked upregulation in response to chronic nicotine (Srinivasan et al., 2011).”
BackgroundMethodInfluentialSelf-citationRichard, M., Boulin, T., Robert, V. J. P., Richmond, J. E., & Bessereau, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216154110 · Cited by 114 · see citing works
Alpha7 nicotinic receptors as therapeutic targets for Parkinson’s disease
Quik, M., Zhang, D., McGregor, M., & Bordia, T. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.014 · Cited by 113 · see citing works
Biogenesis, trafficking and up-regulation of nicotinic ACh receptors
Colombo, S. F., Mazzo, F., Pistillo, F., & Gotti, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.023 · Cited by 118 · see citing works
Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers
Brody, A. L., Mukhin, A. G., Charite, J. L., Ta, K., Farahi, J. B., Sugar, C. A., Mamoun, M. S., Vellios, E. E., Archie, M. M., Kozman, M., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001022 · Cited by 106 · see citing works
“…2009; Quick & Lester, 2002), with this research demonstrating that nAChR up-regulation is post transcriptional (Bencherif et al. 1995; Marks et al. 1992) and that nicotine acts as a stabilizing pharmacological chaperone for nascent a4b2* nAChRs in the endoplasmic reticulum (Srinivasan et al. 2011).”
BackgroundInside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 102 · see citing works
“Without nicotine treatment, a relatively equal proportion of high-and low-sensitivity stoichiometries of a4b2 AChRs are assembled in the TG/TGN (Srinivasan et al., 2011).”
InfluentialSelf-citationPharmacological chaperoning: A primer on mechanism and pharmacology
Leidenheimer, N. J., & Ryder, K. G. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.01.005 · Cited by 102 · see citing works
The Duplicated α7 Subunits Assemble and Form Functional Nicotinic Receptors with the Full-length α7
Wang, Y., Xiao, C., Indersmitten, T., Freedman, R., Leonard, S. S., & Lester, H. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582858 · Cited by 85 · see citing works
“” In the context of analyses presented elsewhere, we believe that the binding fraction is best interpreted as the fraction of donors adjacent to one or more acceptors (23, 28, 31, 32).”
BackgroundSelf-citationLooking below the surface of nicotinic acetylcholine receptors
Stokes, C. A., Treinin, M., & Papke, R. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.05.002 · Cited by 94 · see citing works
Henderson, B. J., Wall, T. R., Henley, B. M., Kim, C. H., Nichols, W. A., Moaddel, R., Xiao, C., & Lester, H. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4194-15.2016 · Cited by 79 · see citing works
“…control nAChR stoichiometry by varying the cDNA levels of each plasmid, and various trafficking processes remain unsaturated, so that individual steps can be studied in early and late exocytotic pathways (Son et al., 2009; Srinivasan et al., 2011, 2012; Xiao et al., 2011; Henderson et al., 2014).”
BackgroundMethodInfluentialSelf-citationNicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors
Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez, D. F., Mackey, E. D. W., McKinney, S., Drenan, R. M., Richards, C. I., & Lester, H. A. (2014) · Journal of General Physiology · doi:10.1085/jgp.201311102 · Cited by 78 · see citing works
“50 nM nicotine caused a significant (P 0.005) threefold increase of ERES in 6-eGFP23 nAChRs but no change in ERES with 6-eGFP23AAA nAChRs (Fig.”
BackgroundMethodInfluentialSelf-citationGillentine, M. A., Yin, J., Bajić, A., Zhang, P., Cummock, S. E., Kim, J., & Schaaf, C. P. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.024 · Cited by 61 · see citing works
Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's disease
Srinivasan, R., Henderson, B. J., Lester, H. A., & Richards, C. I. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.02.005 · Cited by 67 · see citing works
“Proposed mechanisms for upregulation include a decreased degradation of receptors [34], desensitization of surface receptors [35], nicotine acting as a maturational enhancer [36], a novel slow stabilizer [37] and a pharmacological chaperone [30,31,38,39].”
InfluentialSelf-citationKouvatsos, N., Giastas, P., Chroni-Tzartou, D., Poulopoulou, C., & Tzartos, S. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602619113 · Cited by 65 · see citing works
“To emphasize the possible clinical significance of the two subtypes, it has been shown that the stoichiometry of the α4β2 nAChR can be altered by chronic nicotine exposure (28, 30, 31) or by mutations (32).”
BackgroundPuddifoot, C. A., Wu, M., Sung, R., & Joiner, W. J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3630-14.2015 · Cited by 61 · see citing works
“With these ideas in mind, it is notable that nAChRs are “chaperonable” by nicotine, leading to export of receptors from the ER and increased levels at the plasma membrane (Kuryatov et al., 2005; Xiao et al., 2009; Richards et al., 2011; Srinivasan et al., 2011, 2012; Govind et al., 2012).”
BackgroundLive-Cell Imaging of Single Receptor Composition Using Zero-Mode Waveguide Nanostructures
Richards, C. I., Luong, K., Srinivasan, R., Turner, S. W., Dougherty, D. A., Korlach, J., & Lester, H. A. (2012) · Nano Letters · doi:10.1021/nl301480h · Cited by 68 · see citing works
Self-citationDetermining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors
Shivange, A. V., Borden, P. M., Muthusamy, A. K., Nichols, A. L., Bera, K., Bao, H., Bishara, I., Jeon, J., Mulcahy, M. J., Cohen, B. N., et al. (2019) · The Journal of General Physiology · doi:10.1085/jgp.201812201 · Cited by 62 · see citing works
“The epifluorescence cube was previously described (Srinivasan et al., 2011).”
Self-citationSrinivasan, R., Richards, C. I., Xiao, C., Rhee, D., Pantoja, R., Dougherty, D. A., Miwa, J. M., & Lester, H. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.077792 · Cited by 66 · see citing works
Self-citationSrinivasan, R., Henley, B. M., Henderson, B. J., Indersmitten, T., Cohen, B. N., Kim, C. H., McKinney, S. L., Deshpande, P., Xiao, C., & Lester, H. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2126-15.2016 · Cited by 61 · see citing works
“Previous data in transfected cell lines shows that nicotine exposure increases the number of ER exit sites for both 4 2 and 6 2 3 nAChRs, and this metric seems to correlate well with reduction of ER stress (Srinivasan et al., 2011; Henderson et al., 2014).”
BackgroundSelf-citationGeorge, A. A., Bloy, A., Miwa, J. M., Lindstrom, J. M., Lukas, R. J., & Whiteaker, P. (2017) · The FASEB Journal · doi:10.1096/fj.201600733r · Cited by 48 · see citing works
Self-citationAddiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61 · see citing works
Nichols, W. A., Henderson, B. J., Yu, C., Parker, R. L., Richards, C. I., Lester, H. A., & Miwa, J. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573667 · Cited by 58 · see citing works
Self-citationNicotinic receptor and tobacco-related cancer
Russo, P., Cardinale, A., Margaritora, S., & Cesario, A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.003 · Cited by 57 · see citing works
“Moreover, nicotine works as a pharmacological chaperon of nascent nAChR, specifically for α4β2, and then may alter the physiology of endoplasmatic reticulum's processes (Srinivasan et al., 2011).”
BackgroundUsing pharmacological chaperones to restore proteostasis
Wang, Y., Di, X.-J., & Mu, T. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.002 · Cited by 55 · see citing works
Avelar, A. J., Akers, A. T., Baumgard, Z. J., Cooper, S. Y., Casinelli, G. P., & Henderson, B. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107729 · Cited by 56 · see citing works
“Previous investigations have shown that fluorescently-labeled nAChRs behave the same as unlabeled subunits in regard to trafficking and function (Nashmi et al., 2003; Drenan et al., 2008; Srinivasan et al., 2011) and do not alter rodent behavior when expressed in mice (Nashmi et al., 2007).”
BackgroundMethodConduits of Life’s Spark: A Perspective on Ion Channel Research since the Birth of Neuron
Isacoff, E. Y., Jan, L. Y., & Minor, D. L. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.040 · Cited by 57 · see citing works
“, 2010, 2012), we also expect that more insights into molecular mechanism will come from a combination of simulation and experiment (Dror et al., 2012; Ostmeyer et al., 2013; Sauguet et al., 2013; Stansfeld and Sansom, 2011).”
BackgroundPsychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic Effects
Lester, H. A., Miwa, J. M., & Srinivasan, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.020 · Cited by 53 · see citing works
“One could visualize intracellular movements of receptors, transporters, and escorted or abducted proteins as they travel from the ER to axons and dendrites in response to drug actions (16,88).”
Self-citationTrafficking of α4* Nicotinic Receptors Revealed by Superecliptic Phluorin
Richards, C. I., Srinivasan, R., Xiao, C., Mackey, E. D. W., Miwa, J. M., & Lester, H. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256024 · Cited by 54 · see citing works
Self-citationNicotine-Modulated Subunit Stoichiometry Affects Stability and Trafficking of 3 4 Nicotinic Receptor
Mazzo, F., Pistillo, F., Grazioso, G., Clementi, F., Borgese, N., Gotti, C., & Colombo, S. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2393-13.2013 · Cited by 55 · see citing works
“Nicotineenhanced recruitment of subunits into pentamers could explain several functional data of altered receptor stability/ stoichiometry of the 4 2 subtype after nicotine treatment (Srinivasan et al., 2011; Govind et al., 2012).”
BackgroundInfluentialCornichons Control ER Export of AMPA Receptors to Regulate Synaptic Excitability
Brockie, P. J., Jensen, M., Mellem, J. E., Jensen, E., Yamasaki, T., Wang, R., Maxfield, D., Thacker, C. M., Hoerndli, F. J., Dunn, P. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.028 · Cited by 54 · see citing works
“The blue bar indicates the presence of cyclothiazide. were in close apposition to SEC-24/COPII puncta, which mark putative ER export sites (Srinivasan et al., 2011).”
Drenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 51 · see citing works
Self-citationWu, M., Puddifoot, C. A., Taylor, P., & Joiner, W. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.647248 · Cited by 45 · see citing works
Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence
Fowler, C. D., Turner, J. R., & Damaj, M. I. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_252 · Cited by 45 · see citing works
Breitwieser, G. E. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1370 · Cited by 43 · see citing works
Cui, W.-Y., Zhao, S., Polanowska‐Grabowska, R., Wang, J., Wei, J., Dash, B., Chang, S. L., Saucerman, J. J., Gu, J., & Li, M. D. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081497 · Cited by 43 · see citing works
“…substantiates that physiologically relevant manipulations of nAChRs take place in the ER, not at the cell surface membrane (Kuryatov et al., 2005; Srinivasan et al., 2011, 2012), and a sustained interaction between nicotine and nascent nAChRs exerts control over nAChR trafficking (ER export and…”
BackgroundNicotinic Receptor Subtype-Selective Circuit Patterns in the Subthalamic Nucleus
Xiao, C., Miwa, J. M., Henderson, B. J., Wang, Y., Deshpande, P., McKinney, S. L., & Lester, H. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3528-14.2015 · Cited by 39 · see citing works
“…4 2 nAChRs in STN neurons Similar to previous studies in other brain regions (Nashmi et al., 2007; Lester et al., 2009; Son et al., 2009; Xiao et al., 2009a; Srinivasan et al., 2011; Henderson et al., 2014), chronic nicotine upregulated both the number and sensitivity of 4 2* nAChRs in STN (Fig.”
BackgroundSelf-citationLewis, A. S., & Picciotto, M. R. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3126-5 · Cited by 38 · see citing works
“…experiments using optical imaging of tagged nAChR subunits revealed that chronic nicotine exposure stabilized α4β2 receptors in the (α4) 2 (β2) 3 stoichiometry prior to reaching the trans-Golgi network, as well as induced additional ER exit sites (Richards et al. 2011; Srinivasan et al. 2011).”
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors
Letchworth, S. R., & Whiteaker, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.022 · Cited by 39 · see citing works
Xiao, C., Srinivasan, R., Drenan, R. M., Mackey, E. D. W., McIntosh, J. M., & Lester, H. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.005 · Cited by 37 · see citing works
“The increased incidence of α6-eGFPβ2 nAChR currents suggested that introducing β2-DM increased membrane insertion of α6-eGFPβ2 nAChRs, while the ERES marker could facilitate choosing cells expressing functional receptors.”
InfluentialSelf-citationLomazzo, E., Hussmann, G. P., Wolfe, B. B., Yasuda, R. P., Perry, D. C., & Kellar, K. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07408.x · Cited by 37 · see citing works
“2005) and increased subunit assembly via a chaperone effect (Nashmi et al. 2003; Sallette et al. 2004, 2005; Kuryatov et al. 2005; Corringer et al. 2006; Lester et al. 2009; Srinivasan et al. 2010).”
BackgroundInfluentialDendritic trafficking for neuronal growth and plasticity
Ehlers, M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130081 · Cited by 36 · see citing works
McClure‐Begley, T. D., Papke, R. L., Stone, K. L., Stokes, C. A., Levy, A. D., Gelernter, J. E., Xie, P., Lindstrom, J. M., & Picciotto, M. R. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209767 · Cited by 26 · see citing works
“…in the b2 nAChR enhances nAChR transport from the ER, and the effect of the a4R487Q variant is consistent with accelerated nAChR assembly because of enhanced ER transport (Srinivasan et al., 2011), considering the proximity of this variant to an established RxR retention motif in the ha4 subunit.”
BackgroundFrazier, S. J., Cohen, B. N., & Lester, H. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423921 · Cited by 35 · see citing works
“A similar stabilizing effect within the ER appears to underlie nicotine-induced up-regulation of 4 2 nicotinic acetylcholine receptors to the plasma membrane (44).”
BackgroundSelf-citationCooper, S. Y., Akers, A. T., & Henderson, B. J. (2020) · eNeuro · doi:10.1523/eneuro.0172-20.2020 · Cited by 35 · see citing works
“Nicotine has long been known to selectively upregulate high-sensitivity nAChRs, including a4p and a6p nAChRs (Kuryatov et al., 2005; Srinivasan et al., 2011), while menthol (in the absence of nicotine) and cytisine have been shown to upregulate low-sensitivity nAChRs (Srinivasan et al., 2012;…”
BackgroundResultHussmann, G. P., Turner, J. R., Lomazzo, E., Venkatesh, R., Cousins, V., Xiao, Y., Yasuda, R. P., Wolfe, B. B., Perry, D. C., Rezvani, A. H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198085 · Cited by 34 · see citing works
“…within the endoplasmic reticulum, where current evidence indicates that nicotine and presumably varenicline act to increase nAChR density by stimulating assembly of subunits into mature receptors (Sallette et al., 2004, 2005; Kuryatov et al., 2005; Lomazzo et al., 2011; Srinivasan et al., 2011).”
Dau, A., Komal, P., Truong, M., Morris, G., Evans, G., & Nashmi, R. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-47 · Cited by 33 · see citing works
“Pixel-by-pixel based sensitized acceptor FRET microscopy was performed according to previous reports [28-32].”
MethodBrain Region Specific Single-Molecule Fluorescence Imaging
Fu, X., Moonschi, F. H., Fox-Loe, A. M., Snell, A. A., Hopkins, D. M., Avelar, A. J., Henderson, B. J., Pauly, J. R., & Richards, C. I. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02133 · Cited by 25 · see citing works
Ngolab, J., Liu, L., Zhao-Shea, R., Gao, G., Gardner, P. D., & Tapper, A. R. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4453-14.2015 · Cited by 32 · see citing works
“However, a functional increase in activation is observed in chronic nicotine-treated animals, suggesting that upregulation of both 4 and 2 subunits occurs (Srinivasan et al., 2011), leading to the observed increase in nAChR function in GABAergic VTA neurons.”
BackgroundTranscriptional regulation by nicotine in dopaminergic neurons
Henley, B. M., Williams, B. A., Srinivasan, R., Cohen, B. N., Xiao, C., Mackey, E. D. W., Wold, B. J., & Lester, H. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.031 · Cited by 33 · see citing works
Self-citationFu, Y.-L., Han, D., Wang, Y., Di, X.-J., Yu, H. B., & Mu, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207948 · Cited by 27 · see citing works
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease
Iarkov, A., Mendoza, C., & Echeverrı́a, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.665820 · Cited by 34 · see citing works
Fasoli, F., Moretti, M., Zoli, M., Pistillo, F., Crespi, A., Clementi, F., McClure‐Begley, T. D., Marks, M. J., & Gotti, C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.048 · Cited by 33 · see citing works
Mazzaferro, S., Whiteman, S. T., Alcaino, C., Beyder, A., & Sine, S. M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03592-x · Cited by 24 · see citing works
Zarate, S. M., Pandey, G., Chilukuri, S., Garcia, J. A., Cude, B., Storey, S., Salem, N. A., Bancroft, E. A., Hook, M. A., & Srinivasan, R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15282 · Cited by 26 · see citing works
Self-citationSensitization-dependent nicotine place preference in the adult zebrafish
Pisera-Fuster, A., Rocco, L., Faillace, M. P., & Bernabeu, R. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.018 · Cited by 29 · see citing works
Imaging Tobacco Smoking with PET and SPECT
Cosgrove, K., Esterlis, I., Sandiego, C. M., Petrulli, J. R., & Morris, E. D. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_1 · Cited by 29 · see citing works
Nichols, A. L., Blumenfeld, Z., Fan, C., Luebbert, L., Blom, A. E. M., Cohen, B. N., Marvin, J. S., Borden, P. M., Kim, C. H., Muthusamy, A. K., et al. (2022) · eLife · doi:10.7554/elife.74648 · Cited by 25 · see citing works
Self-citationSadigh‐Eteghad, S., Majdi, A., Talebi, M., Mahmoudi, J., & Babri, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.047 · Cited by 28 · see citing works
Fox-Loe, A. M., Moonschi, F. H., & Richards, C. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661827 · Cited by 27 · see citing works
Srinivasan, R., Richards, C. I., Dilworth, C. N., Moss, F. J., Dougherty, D. A., & Lester, H. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810022 · Cited by 26 · see citing works
Self-citationO’Neill, H. C., Laverty, D. C., Patzlaff, N. E., Cohen, B. N., Fonck, C., McKinney, S. L., McIntosh, J. M., Lindstrom, J. M., Lester, H. A., Grady, S. R., et al. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.10.014 · Cited by 27 · see citing works
“$w aterm ark-text $w aterm ark-text $w aterm ark-text changes in subunit stoichiometry, and decreased receptor functionality (Srinivasan et al., 2011;Son et al., 2009;Gentry and Lukas, 2002).”
BackgroundSelf-citationCooper, S. Y., & Henderson, B. J. (2020) · Molecules · doi:10.3390/molecules25184223 · Cited by 28 · see citing works
“As previously stated, high-affinity α4β2 nAChRs are stabilized during this process [37,52,80].”
BackgroundMethodInfluentialJučaitė, A., Öhd, J., Potter, A., Jaeger, J., Karlsson, P., Hannesdóttir, K., Boström, E., NEWHOUSE, P. A., & Paulsson, B. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3116-7 · Cited by 25 · see citing works
Targeting glutamate homeostasis for potential treatment of nicotine dependence
Alasmari, F. F., Al-Rejaie, S. S., AlSharari, S. D., & Sari, Y. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.11.010 · Cited by 24 · see citing works
“The stoichiometry of α4β2 nAChRs was found to be altered after short and long term exposure to nicotine (Nelson et al., 2003, Vallejo et al., 2005, Srinivasan et al., 2011).”
BackgroundBailey, C. D. C., Tian, M. K., Kang, L., O’Reilly, R., & Lambe, E. K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.003 · Cited by 24 · see citing works
“Very little is known about the effects of the inclusion of an a5 subunit on the ability of in vivo nicotine to alter nAChR posttranslational modification or its ability to pharmacologically chaperone nAChRs through the endoplasmic reticulum (Srinivasan et al., 2011).”
BackgroundThe 5-HT3AB Receptor Shows an A3B2 Stoichiometry at the Plasma Membrane
Miles, T. F., Dougherty, D. A., & Lester, H. A. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.07.015 · Cited by 25 · see citing works
Self-citationMicroRNA Regulation of nAChR Expression and Nicotine-Dependent Behavior in C. elegans
Rauthan, M., Gong, J., Liu, J., Li, Z., Wescott, S. A., Liu, J., & Xu, X. Z. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.043 · Cited by 21 · see citing works
“…21, 1434–1441, November 7, 2017 ª 2017 The Au This is an open access article under the CC BY-NC-ND license (http:// tion as a pharmacological chaperon to facilitate maturation, subunit assembly, and trafficking of nAChRs (Sallette et al., 2005; Srinivasan et al., 2011; Vallejo et al., 2005).”
Corrie, L. W.-C., Stokes, C. A., Wilkerson, J. L., Carroll, F. I., McMahon, L. R., & Papke, R. L. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000037 · Cited by 18 · see citing works
Emerging preclinical pharmacological targets for Parkinson's disease
More, S. V., & Choi, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8104 · Cited by 23 · see citing works
Hussmann, G. P., DeDominicis, K. E., Turner, J. R., Yasuda, R. P., Klehm, J., Forcelli, P. A., Xiao, Y., Richardson, J. R., Sahibzada, N., Wolfe, B. B., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12653 · Cited by 23 · see citing works
“, 2012), which is thought to occur in the endoplasmic reticulum (Sallette et al., 2004; 2005; Kuryatov et al., 2005; Srinivasan et al., 2011).”
InfluentialQuantum dot multiplexing for the profiling of cellular receptors
Lee-Montiel, F. T., Li, P., & Imoukhuede, P. I. (2015) · Nanoscale · doi:10.1039/c5nr01455g · Cited by 23 · see citing works
Zugno, A. I., Fraga, D. B., De Luca, R. D., Ghedim, F. V., Deroza, P. F., Cipriano, A. L., Oliveira, M. B., Heylmann, A. S. A., Budni, J., Souza, R. P., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.001 · Cited by 23 · see citing works
Vivekanandarajah, A., Waters, K. A., & Machaalani, R. (2018) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2018.07.007 · Cited by 25 · see citing works
Multidimensional Intersection of Nicotine, Gene Expression, and Behavior
Sherafat, Y., Bautista, M. R., & Fowler, C. D. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.649129 · Cited by 22 · see citing works
“For example, nicotine has been shown to upregulate receptors containing the α4 and β2 nAChR subunits via several mechanisms, including phosphorylation and chaperoning in the endoplasmic reticulum, which could lead to increased receptor insertion at the cell surface (Rothhut et al., 1996; Lester et al., 2009; Wecker et…”
BackgroundCooper, S. Y., Willis, C. V., Richardson, M. R., Hill, S. P., Wright, S. K., Elmore, M. B., Mitchell, Z. B., Castro, A. K. G., & Henderson, B. J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0755-22.2022 · Cited by 21 · see citing works
Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
Fares, M. B., Alijevic, O., Johne, S., Overk, C., Hashimoto, M., Kondylis, A., Adame, A., Dulize, R., Peric, D., Nury, C., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1239009 · Cited by 18 · see citing works
eWang, P., Eshaq, R. S., Meshul, C. K., Moore, C., Hood, R. L., & Leidenheimer, N. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00188 · Cited by 21 · see citing works
Henderson, B. J., Grant, S. N., Wong, B. K., Shahoei, R., Huard, S. M., Saladi, S. M., Tajkhorshid, E., Dougherty, D. A., & Lester, H. A. (2018) · eNeuro · doi:10.1523/eneuro.0465-18.2018 · Cited by 21 · see citing works
“This designation has both analogies and differences with the pharmacological chaperoning of nAChRs by nicotine (Kuryatov et al., 2005; Srinivasan et al., 2011).”
BackgroundMethodSelf-citationBiosensors Show the Pharmacokinetics of S-Ketamine in the Endoplasmic Reticulum
Bera, K., Kamajaya, A., Shivange, A. V., Muthusamy, A. K., Nichols, A. L., Borden, P. M., Grant, S. N., Jeon, J., Lin, E., Bishara, I., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00499 · Cited by 18 · see citing works
“The epifluorescence cube was previously described (Srinivasan et al., 2011).”
Self-citationAlkaloid ligands enable function of homomeric human α10 nicotinic acetylcholine receptors
Hone, A. J., & McIntosh, J. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.981760 · Cited by 19 · see citing works
Pharmacological Chaperones: Beyond Conformational Disorders
Leidenheimer, N. J. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_68 · Cited by 18 · see citing works
Molecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions
Klenowski, P. M., & Tapper, A. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_89 · Cited by 15 · see citing works
Nicotine Acts on Cholinergic Signaling Mechanisms to Directly Modulate Choroid Plexus Function
Lallai, V., Grimes, N. P., Fowler, J. P., Sequeira, P. A., Cartagena, P. M., Limón, A., Coutts, M., Monuki, E. S., Bunney, W. E., Demuro, A., et al. (2019) · eNeuro · doi:10.1523/eneuro.0051-19.2019 · Cited by 19 · see citing works
“…chaperone’ to facilitate the trafficking and insertion of 4-containing and 2- containing nAChR subtypes into the cell membrane (Kuryatov et al., 2005; Srinivasan et al., 2011; Henderson et al., 2014), it is possible that altered expression of nAChRs on the cell membrane could have been induced…”
BackgroundRegulation of Stability and Trafficking of Calcium-Sensing Receptors by Pharmacologic Chaperones
Huang, Y. S., Cavanaugh, A. H., & Breitwieser, G. E. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00007-5 · Cited by 18 · see citing works
“Nicotine can increase both cotranslational stability of [35S]cysteine-labeled nicotinic receptor subunits (Sallette et al., 2005) and enhances maturation rates (Sallette et al., 2005) by facilitating ER exit (Srinivasan et al., 2010).”
BackgroundExpression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 20 · see citing works
Nicotinic Receptors Underlying Nicotine Dependence: Evidence from Transgenic Mouse Models
Gipson, C. D., & Fowler, C. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_134 · Cited by 18 · see citing works
Nichols, A. L., Blumenfeld, Z., Luebbert, L., Knox, H. J., Muthusamy, A. K., Marvin, J. S., Kim, C. H., Grant, S. N., Walton, D. P., Cohen, B. N., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1519-22.2022 · Cited by 15 · see citing works
Self-citationUnparalleled Control of Neural Activity Using Orthogonal Pharmacogenetics
Shapiro, M. G., Frazier, S. J., & Lester, H. A. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300053q · Cited by 16 · see citing works
Self-citationCorsini, S., Tortora, M., & Nistri, A. (2016) · The Journal of Physiology · doi:10.1113/jp272591 · Cited by 16 · see citing works
“2005) and their increased trafficking to lipid raft membrane regions (Kuryatov et al. 2005; Richards et al. 2011; Srinivasan et al. 2011).”
BackgroundHussmann, G. P., Yasuda, R. P., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289546 · Cited by 15 · see citing works
Pubill, D., Garcia‐Ratés, S., Camarasa, J., & Escubedo, E. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.11.008 · Cited by 15 · see citing works
“Such upregulation occurs at a post-translational level and several mechanisms have been proposed to explain it, including a chaperone-like maturation enhancing effect of nicotine (Lester et al., 2009; Kuryatov et al., 2005; Sallette et al., 2005; Srinivasan et al., 2011”
Background
- Authors
- Srinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D. W., Son, C. D., Miwa, J., & Lester, H. A.
- Affiliations
- California Institute of Technology (US)
- Division of Biology MC 156-29, California Institute of Technology, Pasadena, CA 91125
- Corresponding author
- Lester, Henry A.
- Venue
- Journal of General Physiology
- Publisher
- Rockefeller University Press
- Published
- 2010-12-27
- Volume
- 137
- Issue
- 1
- Pages
- 59-79
- ISSN
- 0022-1295 (ISSN-L)
- 1540-7748
- PMC
- PMC3010053
- OpenAlex
- W2156803407
- Semantic Scholar
- 03107ea1f95b064f1bdd12e4782c3c3718021798
- Cited by
- 169
- References
- 74
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 11 · 2018: 7 · 2017: 8 · 2016: 11 · 2015: 18 · 2014: 20 · 2013: 18 · 2012: 19
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of General Physiology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by-nc-sa)
- OpenMETU (Middle East Technical University) (submittedVersion, cc-by-nc-nd)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- Tobacco-Related Disease Research Program (18FT-0066)
- National Institutes of Health (NS-1 1756)
- National Institute on Aging (R01AG033954, AG033954)
- National Institute of Neurological Disorders and Stroke (NS 11756, R01NS011756)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- nicotine, α4β2 nicotinic acetylcholine receptor, receptor up-regulation, ER exit sites, pharmacological chaperones, receptor stoichiometry, ER export, SEC24D, beta2 subunit, ER retention motif, nicotine dependence, Parkinson's disease
- MeSH terms
- Animals, Cell Line, Cell Membrane, Endoplasmic Reticulum, Microscopy, Microscopy, Fluorescence, Nicotine, Receptors, Nicotinic, Tobacco Use Disorder, Transfection, Up-Regulation, Molecular Chaperones, Protein Subunits, Protein Transport, trans-Golgi Network, Fluorescence Resonance Energy Transfer, Vesicular Transport Proteins, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review